Fixation systems and methods

Information

  • Patent Grant
  • 10076377
  • Patent Number
    10,076,377
  • Date Filed
    Friday, March 15, 2013
    11 years ago
  • Date Issued
    Tuesday, September 18, 2018
    6 years ago
Abstract
Embodiments may include fixation devices and methods for securing first and second body tissue portions. Fixation devices may include a base component, an insert component, and a flexible member. The base component may include a passage. The insert component may be positionable within at least a portion of the passage. The elongate member may be configured to be positioned through the first and second body tissue portions. The elongate member may be tensioned and pinched between the base component and insert component to secure the first and second portions.
Description
FIELD

The present disclosure relates to devices and methods for the fixation of tissues and/or implants in a body of a patient. Embodiments may include devices and methods for securing, approximating, and repairing any soft and/or hard body tissue of humans or other animals.


BACKGROUND

Traditional devices and methods may be configured to achieve fixation along a straight line, for example utilizing straight screws, pins, plates, and rods. In many procedures, these devices primarily purchase harder cortical bone and sometimes cancellous bone. Fractures, especially at or near a joint, may include fragments, for example smaller bone fragments and/or soft tissues attached to the bone fragments. The soft tissues connected to the bone fragments may be necessary for blood flow to these bone fragments but are traditionally not addressed. Detaching the soft tissues from the bone fragments may, for example, weaken the muscular attachments and/or devascularize the bone fragments. Traditional techniques lead to further deterioration of tissues surrounding the fracture.


Also, traditional devices may include implants that are designed to stabilize a larger portion of a fracture but may have difficulty securing soft tissue fragments (i.e. connective tissues) and/or hard tissue fragments (i.e. bone) associated with an injury. These tissues may traditionally be left to heal without support, wrapped with a cable, or drilled through then supported with a wire or pin. Traditional methods may result in periosteal stripping and neurovascular injury resulting from placement of the wire. Also, traditional wires and pins are typically smooth and straight thereby providing limited compression across and access to the fracture. Traditional techniques may be unable to capture soft and hard tissue fragments.


In addition, traditional devices and methods do not secure articular surface fragments. The articular surface must move relative to the adjacent tissues, so a traditional fixation device grabbing an articular surface fragment risks damage to the articular cartilage and the bone on the opposing side of the joint. For example, if the humeral articular surface is damaged, traditional methods do not provide a consistent way to repair the humeral articular cartilage back to its normal size and position. More rigid fixation may damage the glenoid of the articular surface on the opposing side of the joint as the shoulder moves through its range of motion. Traditional techniques are unsuitable for articular surfaces.


There exists a need for a system to repair and secure soft tissue fragments (i.e. muscle, tendon, ligament, and/or articular cartilage) along with hard tissue fragments (i.e. bone). Furthermore, there is a need for a system to repair traditionally unsecured soft tissue fragments thereby stabilizing soft and hard tissue fragments together as a unit. The fixation systems disclosed herein, for example deformable, suture material, and/or mesh fasteners, may secure hard and soft tissue fragments to another device (i.e. plate, screw, and rod), for example, to increase stability. The systems herein may allow capture of a hard tissue fragment (i.e. bone) of a fracture and closure the fracture with a desired compression. This may promote improved tissue healing and/or alleviate issues associated with traditional fixation systems. The systems disclosed herein may be a unitary or standalone solution or be coupled with plates, rods, screws, cables, pins, wires, and/or any traditional system.


SUMMARY

As is described in further detail below, embodiments may include a system for securing first and second body tissue portions of a fracture. Fixation devices may include a base component, an insert component, and a flexible member. The base and/or insert components may include a passage. The insert component may be positionable within at least a portion of the passage of the base component. The elongate member may be configured to be positioned through the first and second body tissue portions. The elongate member may be tensioned and pinched between the base component and insert component or within the passage of the insert component, for example, to secure the first and second body tissue portions.


Further embodiments may include a fixation device, an elongate member, and a bone clamp. The elongate member may be configured to be positioned through first and second body tissue portions. The bone clamp may be configured to urge the first and second body tissue portions together. The elongate member may be tensioned and secured with the fixation device to secure the first and second body tissue portions.


In another embodiment, a system may include a base component, insert component, fastener, and elongate member. The base component may include a passage. The insert component may be positionable within at least a portion of the passage of the base component. The fastener may be configured to be positioned through the first and second body tissue portions and on a distal tissue surface. The elongate member may be configured to connect the fastener on the distal body tissue surface and positioned between the base component and insert component on a proximal tissue surface. The elongate member may be tensioned and pinched between the base component and insert component to secure fixation device relative to the elongate member thereby securing the first and second tissue portions.


Embodiments may also include methods of positioning first and second body tissue portions. Methods may include passing a fastener connected to an elongate member through first and second body tissue portions, securing the fastener relative to a distal body tissue surface, positioning a base component of a fixation device along the elongate member, tensioning the elongate member, and/or positioning an insert component of a fixation device into a portion of the base component and against the elongate member. The elongate member may be pinched between the base component and insert component thereby securing the first and second body tissue portions relative to each other.


As an additional embodiment, methods may include positioning a fixation system for securing a fracture of a joint of a body. The method may comprise passing a fastener connected to an elongate member through proximal and distal fragments of the fracture, positioning the fastener against the distal fragment, securing a plate with respect to the proximal fragment, tensioning the elongate member to urge the first and second fragments together, and/or locking a fixation device against the elongate member and the plate.


Further embodiments may include a method of using a fixation system to repair a defect in a passage. The method may comprise positioning an implant disposed over an introducer adjacent the defect in the passage, expanding the introducer radially to urge the implant against the passage, contracting the introducer radially while the implant remains expanded against the passage; and retracting the introducer axially while the implant remains in the passage.


Additional embodiments of the present disclosure are provided throughout this disclosure including the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete understanding of the present disclosure, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:



FIG. 1 illustrates an isometric view of an embodiment of the present disclosure, for example, including a base component, an insert component, and an elongate member of a fixation device;



FIG. 2 illustrates a front view of an embodiment of FIG. 1;



FIG. 3 illustrates a top view of an embodiment of FIG. 1;



FIG. 4 illustrates a front section view of an embodiment of FIG. 1;



FIG. 5 illustrates an isometric view of a base component;



FIG. 6 illustrates a front view of an embodiment of FIG. 5;



FIG. 7 illustrates a top view of an embodiment of FIG. 5;



FIG. 8 illustrates a front section view of an embodiment of FIG. 5, for example, including a tapered inner surface;



FIG. 9 illustrates an isometric view of an insert component of a fixation device, for example, including an external tapered surface and/or an internal attachment feature;



FIG. 10 illustrates a front view of an embodiment of FIG. 9;



FIG. 11 illustrates a top view of an embodiment of FIG. 9, for example, including a passage;



FIG. 12 illustrates a section view of an embodiment of FIG. 9, for example, including an internal attachment feature;



FIG. 13 illustrates an isometric view of an alternative embodiment, for example, including a base component, an insert component, and an elongate member of a fixation device;



FIG. 14 illustrates a front view of an embodiment of FIG. 13;



FIG. 15 illustrates a top view of an embodiment of FIG. 13;



FIG. 16 illustrates a front section view of an embodiment of FIG. 13, for example, including internal and external attachment features;



FIG. 17 illustrates an isometric view of an alternative embodiment, for example, including an alternative base component;



FIG. 18 illustrates a front view of an embodiment of FIG. 17;



FIG. 19 illustrates a top view of an embodiment of FIG. 17;



FIG. 20 illustrates a front section view of an embodiment of FIG. 17, for example, including a passage with two or more tapers and/or diameters;



FIG. 21 illustrates an isometric view of an alternative embodiment, for example, including an alternative base component;



FIG. 22 illustrates a front view of an embodiment of FIG. 21;



FIG. 23 illustrates a top view of an embodiment of FIG. 21;



FIG. 24 illustrates a front section view of the embodiment of FIG. 21, for example, including an internal attachment feature;



FIG. 25 illustrates an isometric view of an alternative embodiment, for example, including an alternative insert component having a head portion and a body portion;



FIG. 26 illustrates a front view of the embodiment of FIG. 25;



FIG. 27 illustrates a top view of an embodiment of FIG. 25;



FIG. 28 illustrates a front section view of an embodiment of FIG. 25;



FIG. 29 illustrates an isometric view of an alternative embodiment, for example, including an alternative insert component;



FIG. 30 illustrates a front view of an embodiment of FIG. 29;



FIG. 31 illustrates a top view of an embodiment of FIG. 29;



FIG. 32 illustrates a front section view of an embodiment of FIG. 29;



FIG. 33 illustrates an isometric view of an alternative embodiment, for example, including, an alternative insert component of the fixation device;



FIG. 34 illustrates a front view of an embodiment of FIG. 33;



FIG. 35 illustrates a top view of an embodiment of FIG. 33;



FIG. 36 illustrates a front section view of an embodiment of FIG. 33, for example, including an external attachment feature;



FIG. 37 illustrates an isometric view of an alternative embodiment, for example, including an alternative base component;



FIG. 38 illustrates an isometric view of an alternative embodiment, for example, including another alternative base component;



FIG. 39 illustrates an isometric schematic of an embodiment, for example positioned with respect to a tissue fracture;



FIG. 40 illustrates a side view of an embodiment of FIG. 39;



FIG. 41 illustrates another side view of an embodiment of FIG. 39;



FIG. 42 illustrates a side section view of an embodiment of FIG. 39;



FIG. 43 illustrates a front isometric view of an embodiment of the present disclosure, for example, including a plate and screws positioned with respect to a tissue fracture;



FIG. 44 illustrates a back isometric view of an embodiment of FIG. 43;



FIG. 45 illustrates a back isometric view of an alternative embodiment of FIG. 43;



FIG. 46 illustrates an isometric view of an embodiment, for example, including repair of a tissue fracture of the lesser trochanter of a femur;



FIG. 47 illustrates an alternative view of an embodiment of FIG. 46, for example, including one or more fixation devices;



FIG. 48 illustrates an alternative view of an embodiment of FIG. 46, for example including one or more fasteners;



FIG. 49 illustrates an alternative embodiment of FIG. 48, for example, including one or more alternative fasteners;



FIG. 50 illustrates an isometric view of an embodiment, for example, including repair of a tissue fracture of the greater trochanter of the femur;



FIG. 51 illustrates an alternative view of an embodiment of FIG. 50, for example, including one or more fixation devices;



FIG. 52 illustrates an alternative view of an embodiment of FIG. 50, for example, including one or more fasteners;



FIG. 53 illustrates an alternative embodiment of FIG. 50, for example, including one or more alternative fasteners;



FIG. 54 illustrates an embodiment the present disclosure, for example, including repair of a tissue fracture of the greater tuberosity of the humerus;



FIG. 55 illustrates a top view of the embodiment of FIG. 54;



FIG. 56 illustrates a side section view of the embodiment of FIG. 54, for example, including soft and/or hard tissue fixation;



FIG. 57 illustrates an alternative embodiment of FIG. 54, for example, including a plate and screws;



FIG. 58 illustrates an embodiment of the present disclosure, for example, including clamp configured to reduce and/or cut a tissue fracture;



FIG. 59 illustrates an isometric view of an embodiment of FIG. 58, for example, positioned to secure and/or repair a lesser trochanter of a femur;



FIG. 60 illustrates a section view of an embodiment, for example, including repair of a tissue fracture of a proximal femur;



FIG. 61 illustrates an alternative section view of an embodiment of FIG. 60;



FIG. 62 illustrates an alternative section view of an embodiment of FIG. 60;



FIG. 63 illustrates an isometric view of an embodiment, for example, including a fastener attached to an introducer such as an awl;



FIG. 64 illustrates a closer view of an embodiment of FIG. 63;



FIG. 65 illustrates an alternative view of an embodiment of FIG. 64, for example a deployed configuration;



FIG. 66 illustrates an alternative view of an embodiment of FIG. 63, for example, including an attachment feature;



FIG. 67 illustrates an isometric view of an alternative embodiment, for example, including an alternative fastener configured to receive an elongate member in at least two locations;



FIG. 68 illustrates an alternative view of an embodiment of FIG. 67;



FIG. 69 illustrates an alternative embodiment of FIG. 67, for example, a fastener configured to receive an elongate member in at least three locations;



FIG. 70 illustrates an alternative view of an embodiment of FIG. 69;



FIG. 71 illustrates an alternative embodiment of FIG. 67;



FIG. 72 illustrates an alternative view of the embodiment of FIG. 71;



FIG. 73 illustrates an alternative embodiment of FIG. 67, for example, a fastener configured to receive an elongate member in at least four locations;



FIG. 74 illustrates an alternative view of an embodiment of FIG. 73;



FIG. 75 illustrates an alternative embodiment of FIG. 67;



FIG. 76 illustrates an alternative view of an embodiment of FIG. 75;



FIG. 77 illustrates an alternative embodiment of FIG. 67;



FIG. 78 illustrates an alternative view of an embodiment of FIG. 77;



FIG. 79 illustrates an alternative embodiment of FIG. 67, for example, a fastener configured to receive an elongate member in at least six locations;



FIG. 80 illustrates an alternative view of an embodiment of FIG. 79;



FIG. 81 illustrates an isometric view of an alternative embodiment, for example, including an alternative fastener having two or more components in an initial configuration;



FIG. 82 illustrates an embodiment of FIG. 81, for example, in a second configuration;



FIG. 83 illustrates an alternative embodiment of FIG. 81, for example, in an initial configuration;



FIG. 84 illustrates an embodiment of FIG. 83, for example, in a second configuration;



FIG. 85 illustrates an alternative embodiment of FIG. 81, for example, in an initial configuration;



FIG. 86 illustrates an embodiment of FIG. 85, for example, in a second configuration;



FIG. 87 illustrates an alternative embodiment of FIG. 81, for example, in an initial configuration;



FIG. 88 illustrates an embodiment of FIG. 87, for example, in a second configuration;



FIG. 89 illustrates an isometric view of an embodiment, for example, including repair of an avulsion fracture with a knee replacement;



FIG. 90 illustrates a section view of an embodiment of FIG. 89;



FIG. 91 illustrates section view of an embodiment, for example, including repair of an avulsion fracture with a hip replacement;



FIG. 92 illustrates an alternative embodiment, for example, an act for repairing an articular surface cartilage defect including creating one or more passages in the tissue;



FIG. 93 illustrates an embodiment of FIG. 92, for example, including an act of inserting a fastener connected to an elongate member through the passage and positioning the fixation device at a distal area;



FIG. 94 illustrates an embodiment of FIG. 92, for example, including an act of deploying a fastener to approximate a natural curvature of an articular surface;



FIG. 95 illustrates an embodiment of FIG. 92, for example, including an act of securing a fastener with one or more fixation devices at a proximal area;



FIG. 96 illustrates an embodiment of the present disclosure, for example, including a passage with a defect;



FIG. 97 illustrates a section view of an embodiment of FIG. 96;



FIG. 98 illustrates an embodiment of FIG. 96, for example, including an alternative fixation device being positioned on an expandable device in the passage of FIG. 96;



FIG. 99 illustrates an embodiment of FIG. 96, for example, including the expandable device urging radial expansion of a fixation device with an expanded configuration;



FIG. 100 illustrates an embodiment of FIG. 96, for example, deploying of the fixation device and retracting the expandable device in a contracted configuration;



FIG. 101 illustrates an embodiment of FIG. 96, for example, the fixation device deployed and positioned against the passage; and



FIG. 102 illustrates an isometric view of an alternative embodiment of FIG. 58, for example, including a clamp configured to reduce a tissue fracture;



FIG. 103 illustrates a side view of the embodiment of FIG. 102, for example positioned to hook around a portion of at least two tissue fragments;



FIG. 104 illustrates a section view of the embodiment of FIG. 102, for example, urging together two tissue fragments;



FIG. 105 illustrates an isometric view of an alternative embodiment of FIG. 102, for example, including a cutting device;



FIG. 106 illustrates a section view of an embodiment of FIG. 105, for example, including the cutting device configured to penetrate tissue of a fracture;



FIG. 107 illustrates a section view of an embodiment of FIG. 102, for example including positioning a fastener and/or elongate member through the tissue fracture with a pushrod;



FIG. 108 illustrates a section view of an embodiment of FIG. 102, for example with the fastener positioned at a distal area and the pushrod removed;



FIG. 109 illustrates an isometric view of an alternative embodiment of FIG. 102, for example, including a device configured to tension the elongate member and press the pushrod;



FIG. 110 illustrates a section view of an embodiment, for example, including an alternative fixation device;



FIG. 111 illustrates a section view of an embodiment, for example, including another alternative fixation device;



FIG. 112 illustrates a section view of an embodiment, for example, including another alternative fixation device;



FIG. 113 illustrates a section view of an embodiment, for example, including another alternative fixation device;



FIG. 114 illustrates a side view of an embodiment, for example, including an alternative insert component in a contracted configuration;



FIG. 115 illustrates a side view of an embodiment of FIG. 114, for example, including an expanded configuration;



FIG. 116 illustrates a side view of an alternative embodiment, for example, including an alternative fastener positionable with an introducer;



FIG. 117 illustrates an alternative embodiment of FIG. 116, for example, including an alternative fastener;



FIG. 118 illustrates an alternative embodiment of FIG. 116, for example, including another alternative fastener.



FIG. 119 illustrates an isometric view of an embodiment of FIG. 57;



FIG. 120 illustrates an embodiment of FIGS. 60-62, for example, including an implant such as a nail or rod;



FIG. 121 illustrates an embodiment of FIG. 119-120, for example, including a fastener connected to a head of a screw; and



FIG. 122 illustrates an embodiment of the present disclosure, for example, including an implant such as a scaffold.





DETAILED DESCRIPTION

The present disclosure relates to devices and methods for fixation of tissues in a body of a human or other animal. Embodiments may include a fixation device comprised of a single or one or more components. The fixation device may be attached relative to an elongate member, for example, to secure soft and/or hard body tissues. The fixation device may be used alone, with one or more other fixation devices, or may be used with fasteners, screws, plates, rods, cables, pins, and/or wires. One or more fixation device may be utilized to secure a single or one or more elongate members.


Embodiments may relate to the repair, reconstruction, augmentation, and stabilization of tissue and/or implants. Embodiments may be utilized during a medical procedure and/or “on the way out” after the procedure has been performed. Hard and/or soft tissue at and around the procedure site and the tissue between the procedure site and the skin incision may be compressed and/or repaired. This may entirely or partially restore tissue function and/or stabilize the treatment area for enhanced healing. The embodiments herein may be used with any medical or surgical procedure, for example a ligament repair, tendon repair, muscle repair, bone repair, cartilage repair, and repair of any other tissue type. Ligaments may be fastened to ligaments, ligaments to bones, bones to bones, ligaments to muscles, muscles to muscles, tissue grafts to bone, tissue grafts to ligaments, grafts to grafts, and any other combination of tissues and/or implants. The embodiments herein may be utilized with minimally invasive techniques.


Embodiments herein may be configured to repair soft tissue (i.e. muscle, tendon, ligament, and/or articular cartilage) fragments along with hard tissue (i.e. bone) fragments together as a unit. Traditional screws and pins may be insufficient to stabilize the fragments. However, fixation devices, for example including deforming, all suture material, and/or mesh fasteners, may grab and stabilize bone along with muscles, tendons, ligaments, and/or articular cartilage. Also, fixation devices may reattach these tissues to larger structures (i.e. plates, screws, rods, and/or other implants) to create a more stable construct.


Further embodiments may be configured for soft tissue fragments, for example, to restore an articular surface. For example, a deformable fastener connected to an elongate member may be positioned through an articular cartilage fragment to pull the articular cartilage fragment to the articular surface. This may facilitate range of motion of the joint while minimizing damage to the bone on the opposite side of the joint, for example a glenoid or any other joint surface.


The technologies disclosed herein also allow for fixation of bone-to-bone, tissue-to-bone, and/or tissue-to-tissue. Bone fractures may damage the soft tissues (i.e. tendons and/or ligaments) near the fracture. The embodiments herein may allow for a composite system that may provide stability while repairing the tissue around the fracture. For example, embodiments may be used to repair an anterior cruciate ligament (ACL) or stabilize an ACL graft, allograft and/or autograft. Embodiments may also be used for rotator cuff tendon repair in which the tendon could be repaired around the tendon or around the bone. Also, bone-to-bone fixation may be achieved by grasping the tendon bone construct.


Embodiments may provide broader capabilities in fixing different types of fracture fragments. In situations with osteoporotic bone or other deteriorated tissues, the tendon-bone interface or ligament-bone interface may be stronger than an osteoporotic or deteriorated cortical portion. Fixation may be achieved by securing to the tendon or ligament portion, which may be more stable than grabbing the osteoporotic bone fragment alone. As another example, embodiments may be used in pediatric fractures where there may be a growth plate-epiphysis. An elongate member may be positioned through the epiphysis without the unnecessary bone growth restriction that may be a consequence of rigid fixation such as a screw, plate, or rod. The embodiments herein may be configured for soft tissue fixation by providing an angle, bend, or curve to avoid or access through a passage through the epiphysis. These techniques may facilitate treatment while preserving tissue and/or reducing growth abnormalities.


In an embodiment, devices and methods for stabilizing and/or repairing a body joint may be provided. A fixation device (i.e. a fastener) may be positioned in contact with a first body tissue, for example, on one side of the joint (i.e. at a distal area). Another fixation device may be positioned in contact with second body tissue, for example, on the other side of the joint (i.e. at a proximal area). An elongate member may be positioned and/or connected between the fixation devices and/or tensioned. The tensioned elongate member may be secured to the fixation devices, for example, to restrict or restore normal movement of the joint. The fixation devices may be positioned in contact with any outer or inner surface of the body.


The elongate member may be positioned adjacent to and/or through the tissue, for example, of the joint. The elongate member may include a suture, wire, cable, or any combination thereof. Elongate members may be flexible or bendable. The elongate member may include one or more flexible filaments. All or any portion of elongate member may be degradable, biodegradable, bioabsorbable, or non-biodegradable. The elongate member may be configured to change shape or dimensions with energy, for example thermal or vibratory energy (i.e. ultrasonic energy). Elongate member may tighten, loosen, and/or contract with heat. Heat may include body heat a portion of the body or applied thermal or vibratory energy. The elongate member may include polyethylene, polyester, cat gut, silk, nylon, polypropylene, linen, cotton, PLA, PGA, caprolactam, and copolymers of glycolic and lactic acid. The elongate member may be threadlike, monofilament, multifilament, braided, woven, or inter-laced. The elongate member may include a coating of therapeutic substances or drugs. The elongate members may include anti-biotics, hydroxyapatite, anti-inflammatory agents, steroids, antibiotics, analgesic agents, chemotherapeutic agents, bone morphogenetic protein, demineralized bone matrix, collagen, growth factors, autogenetic bone marrow, progenitor cells, calcium sulfate, immunosuppressants, fibrin, osteoinductive materials, apatite compositions, fetal cells, stem cells, enzymes, proteins, hormones, and germicides.


Body tissue may include any soft tissue, hard tissue, or any combination thereof. Body tissues may include bones, muscles, ligaments, tendons, nerves, fascia, skin, fibrous tissues, fat, synovial membranes, organs, collagen, cartilage, fascia, blood vessels, and tissue grafts. These may be tissues of any portion of the body, for example a knee, ankle, elbow, wrist, feet, hand, hip, shoulder, jaw, and spine. Bones of the knee may include the femur, tibia, and patella. Ligaments of the knee may include the medial collateral ligament, lateral collateral ligament, posterior oblique ligament, arcuate ligament, oblique popliteal ligament, anterior cruciate ligament, and posterior cruciate ligament. Bones of the spine may include transverse process, pedicle, facet, spinous process, posterior arch, odontoid process, posterior tubercle, lateral articular process, uncinate process, anterior tubercle, carotid tubercle, lamina, and vertebral body. Ligaments of the spine may include the anterior longitudinal ligament, posterior longitudinal ligament, interspinous ligaments, supraspinous ligament, ligamentum flavum, intertransverse ligament, facet capsulary ligament, ligamentum nuchae, and ligaments of the sacrum and coccyx spine. Tissue grafts may include a xenograft, allograft, autograft, and/or synthetic graft material. Embodiments may also be made from a porous matrix or mesh of biocompatible and bioresorbable fibers acting as a scaffold to regenerate tissue. Embodiments may be configured to repair or stabilize articular surfaces, metaphyseal areas, periarticular fractures, implants (i.e. cochlear implants), oral or facial injuries (i.e. oral maxillary facial injuries), and arthroplasty components of any joint including the spine.


Further embodiments may be degradable, biodegradable, bioerodible, bioabsorbable, mechanically expandable, hydrophilic, bendable, deformable, malleable, riveting, threaded, toggling, barbed, bubbled, laminated, coated, blocking, pneumatic, one-piece, Morse taper, single piece, multi-component, solid, hollow, polygon-shaped, pointed, locking and unlocking, self-introducing, knotless, and combinations thereof. Also, embodiments may include a metallic material, polymeric material, ceramic material, composite material, body tissue, synthetic tissue, hydrophilic material, expandable material, compressible material, heat bondable material, biocompatible adhesive, porous material, matrix or mesh material, and combinations thereof. All or any portion of the embodiments herein may include an expandable material and/or an expandable coating. The embodiments may be configured to be compressed then expanded. Alternatively, embodiments may be hydrophilic, expandable with liquid, PEEK, PTFE, desiccated body tissue, and/or any other material disclosed herein. Embodiments may include any combination of materials disclosed herein. For example, embodiments may include combinations of hydrophilic material, synthetic body tissue, collagen, synthetic collagen, heat bonded material, biocompatible adhesive, and cells (i.e. stem cells). Embodiments may include or be used in conjunction with any devices and methods disclosed in U.S. Pat. No. 5,718,717, titled “Suture Anchor”, which is hereby incorporated by reference in its entirety.


Embodiments may be any of biocompatible, degradable, biodegradable, bioerodible, bioabsorbable, mechanically expandable, hydrophilic, bendable, deformable, malleable, riveting, threaded, toggling, barbed, bubbled, laminated, coated, blocking, pneumatic, one-piece, multi-component, solid, hollow, polygon-shaped, pointed, self-introducing, mesh, segmented, tubular, braided, suture material, elastic (i.e. rubber, silicone, or any other elastic material), and combinations thereof. Furthermore, embodiments may include any of a metallic material, polymeric material, ceramic material, composite material, body tissue, synthetic tissue, hydrophilic material, expandable material, compressible material, bondable material, and combinations thereof. Embodiments may also include polymethyl methacrylate (PMMA or “bone cement”), glue, adhesive, grouting agents, acrylic materials, and combinations thereof.


Additional embodiments herein may include any biocompatible materials or any other materials suitable for medical use. All or any portion of the embodiments herein may be any metallic, non-metallic, composite, ceramic, polymeric, copolymeric, biologic, or synthetic material or any combination thereof. Embodiments may include portions and/or combinations of metals and polymers. Embodiments may include shape memory alloys (SMA) and/or shape memory polymers (SMP). Examples of amorphous polymers are polycarbonate (LEXAN), polystyrene, polysulfone (ULDALL), and acrylics polycarbonate (ABS and styrenes). Examples of semi-crystalline polymers include acetyl (DELRIN), nylon, polyester, polyethylene, polyether ether ketone, polypropylene, polyvinylchloride (PVC), and Caprolactam. Biodegradable semi-crystalline polymers may include polylactic acid and polyglycolic acid. Copolymers of PGA and PLA may also be used. Poly-1-lactide (PLLA) or other forms of PLA may also be used. Other polymers which may be used with the present invention, either as a thermoplastic or non-thermoplastic, are polyethylene glycol (PEG)-copolymers and D,L-lactide-co-glycolide polyesters. Some semi-crystalline materials are particularly suitable for surgical bonding and/or staking, especially vibratory bonding and staking Examples of such materials include PAEK (polyaryletherketone), PEEK (polyetheretherketone) and PEKK (polyetherketoneketone). Metals include stainless steel, shape metal alloys, tantalum, porous tantalum, titanium, and cobalt-chrome alloys. Shape memory alloys may include nitinol (nikel-titanium). Shape memory polymers may include PEEK, PMMA, and thermoset polymers. Thermoset polymers may include polyurethanes, polyethylene terephthalate (PET), polyethyleneoxide (PEO), block copolymers containing polystyrene and poly(1,4-butadiene), and ABA triblock copolymers, for example including poly(2-methyl-2-oxazoline) and polytetrahydrofuran. Ceramic materials (i.e. implants) may include silicon nitride, alumina (aluminum oxide), and zircon (zirconium dioxide). Embodiments may include materials configured to resist growth of bacteria and/or biofilm, for example silicon nitride.


Embodiments may be configured to access any treatment site, for example any portion of the body. Embodiments may be configured to transfer objects and/or materials into and/or from the treatment site. Embodiments may utilize a natural body passage or create a passage. The passage may be created through soft or hard tissue. Embodiments may be partially or entirely flexible, curved, non-linear, bendable, and/or may have shape memory properties or materials, which may allow all or any portion of the system to change in shape. A change in shape may include a change in angle, which may range between about 0-180 degrees. Use of a shape memory material may allow the angle to vary within a range of about 0-180 degrees with a change in temperature and/or by the application of heat. Embodiments may be shaped and/or positioned to access a curved or natural anatomic path through the body. Embodiments may be used in conjunction with any devices or methods disclosed in U.S. Pat. No. 6,814,715, titled “Expandable Cannula”, U.S. Patent Application Publication Nos. 2011/0202123, titled “Anatomic Needle System” and 2011/0224539, titled “Methods for Positioning an Ultrasonic Catheter”, and U.S. patent application Ser. No. 13/683,847, titled “Expandable Access Systems and Methods”, all of which are hereby incorporated by reference in their entirety.


The methods and devices disclosed herein may be used in conjunction with any medical procedure. Embodiments may be used before, during, or after a procedure. Treatment areas may include any cavity, vessel, duct, passage, joint, bone, muscle, ligament, tendon, cartilage, capsule, organ, skin, nerve, or other body parts. Embodiments may be used for applications related to biliary ducts, bronchi (i.e. cystic fibrosis), kidney stones, bile ducts, sinus ducts, bone cavities, the vasculature, and any other site in the body. As further examples, embodiments herein may be used in or in conjunction with other medical instruments during sinuplasty, lithotripsy, intervertebral disc surgery, kyphoplasty, knee surgery, hip surgery, organ transplant surgery, bariatric surgery, spinal surgery, anterior cruciate ligament (ACL) surgery, tendon-ligament surgery, rotator cuff surgery, capsule repair surgery, fractured bone surgery, pelvic fracture surgery, avulsion fragment surgery, shoulder surgery, hernia repair surgery, and surgery of an intrasubstance ligament tear, annulus fibrosis, fascia lata, or flexor tendons. Treatment areas include the ear, prostate, biliary ducts, bronchi (i.e. cystic fibrosis), kidney stones, bile ducts, sinuses (i.e. sinusitis), small or large intestines (i.e. diverticulitis), bone cavities, and/or vasculature. Embodiment may be used in any medical application or body portion disclosed herein, disclosed in the incorporated references, or known in the art.


Embodiments may be configured to be used in conjunction with other medical instruments or implants. Embodiments may be configured to position and/or prepare the treatment site for another medical instrument or implant. Instruments may include any dilator, trocar, introducer, imaging device, or any other device or material disclosed herein. Implants may include a coronary artery stent, vascular stent, peripheral vascular stent, urinary tract stent, or urethral stent. Implants may include a partial or total knee replacement, hip replacement, shoulder replacement, bone fastener, etc. Objects may include an organ, partial organ grafts, tissue graft material (i.e. autogenic, allogenic, xenogenic, or synthetic), collagen, a malleable implant like a sponge, mesh, bag/sac/pouch, collagen, or gelatin, or a rigid implant made of metal (i.e. porous or nonporous), polymer, composite, or ceramic. Other implants include breast implants, biodegradable plates, porcine or bovine patches, metallic fasteners, compliant bearing for medial compartment of the knee, nucleus pulposus prosthetics, stents, fasteners, sutures, suture anchors, tissue grafts, or tissue scaffolds.


Tissue scaffolds may include any biologic, synthetic, biodegradable, collagen, polymeric and/or biocompatible scaffold. The scaffold may include a collagen matrix configured to receive viable cells of any type. The matrix may be utilized as a support structure for cells. Different types of cells may be placed at various locations in the matrix. The matrix may be positioned relative to any portion of a patient's body, for example all or any portion of a heart, blood vessel, brain, intestine, stomach, adrenal gland, liver, pancreas, bone, skeleton, spinal cord, or any other organ or any soft or hard tissue. The cell types may include progenitor cells which differentiate and proliferate to form cells having desired characteristics, stromal cells which relate to foundation supporting tissue, and mesenchymal cells which relate to connective tissues, blood and blood vessels, and other systems. Fibroblasts may be used in the production of connective tissues. Osteoblasts may be used in the production of hard tissue (i.e. bone). Myoblasts may be used in the production of muscle. Specific cells may be used to provide for growth of tissue having a function associated with the cell, which may include reticular cells, smooth muscle cells, chondrocytes, retinal cells, endothelial cells, fetal cells, stem cells, embryonic cells, adult cells, enzymes, proteins, and/or other cells disclosed herein or known in the art. Once the viable cells have been positioned on the matrix, the result is a replacement tissue (i.e. an organ). Embodiments of the present disclosure may include the additional devices and methods disclosed in U.S. Pat. No. 7,299,805, titled “Scaffold and Method for Implanting Cells”, which is hereby incorporated by reference in its entirety. Embodiments may also include biofilm that is sterilized to allow sterile biofilm to be used as an adhesive for scaffolds or used as a drug release agent.


Referring to the FIGS. 1-38, embodiments may include fixation device 100. Fixation device 100 may include any or all of base component 102, insert component 104, and/or elongate member 106. Fixation device 100 may be positionable with respect to any body tissue or portion of the body. Fixation device 100 may be positionable at a distal tissue area or a proximal tissue area. Fixation device 100 may include fastener 116.


Base component 102 may include elongate and/or cylindrical body 110 and head portion 108, which may include one, two, or more tabs that may be configured to be positioned on a surface of a body tissue. (FIG. 2). Base component 102 may include a passage through all or any portion of its length. (FIG. 3-4). Base component 102 may be configured to directly contact and/or fit into the body tissue. Base component 102 may be positionable in a body tissue hole that is natural, drilled, punched, cut, or formed. Leading portion 110 of base component 102 may be positionable into the body tissue. Head portion 108 may be configured to retain insert component 104. Head portion 108 may assist in the positioning of base component 102 and/or resist recession of base component 102 into the body tissue hole. Base component 102 may be positioned with elongate member 106 passing through all or any portion of the length of base component 102. (FIG. 4).


Insert component 104 may be positionable in all or any portion of the passage of base component 102 or into any other embodiment herein. (FIG. 4). Insert component 104 may be positioned before, during, or after base component 102 is positioned in the body of the patient. Insert component 104 may be secured in the passage of base component 102 to secure elongate member 106 with respect to body tissue and/or additional fixation devices. Elongate member 106 may be secured with mechanical features, press fitting, screwing, crimping, squeezing, melting, thermal or ultrasonic joining, gluing, or any other method disclosed herein.


Fixation device 100 may include one or more tapers. (FIG. 4). Base component 102 and/or insert component 104 may include a taper on any surface, for example any interior and/or exterior surface. The taper may be configured to progressively increase and/or decrease along its length or circumference, for example, to provide varying fixation relative to elongate member 106. An interior surface taper of base component 102 may be configured to approximate an exterior surface taper of insert component 104. The taper may provide additional locking as elongate member 106 is tensioned through a tissue passage and/or insert component 104 is urged into base component 102. Insert component 104 (i.e. outer surface) and base component 102 (i.e. inner surface of the passage) may include tapered surfaces along all or a portion of their length, for example, to accentuate locking and/or securing of elongate member 106. Elongate member 106 may be secured by trapping elongate member 106 between base component 102 and insert component 104, for example, when insert component 104 is pressed into the passage of base component 102.


Elongate member 106 may be secured at any point along its length. Elongate member 106 may include a suture, wire, cable, pin, screw, elongate device, fastener, any combination thereof, or any other device disclosed herein. All or any portion of base component 102, insert component 104, and/or elongate member 106 may deform relative to each other, for example, to secure elongate member 106. (FIG. 4). All or any portion of base component 102, insert component 104, and/or elongate member 106 may be bonded, deformed, and/or secured relative elongate member 106.


Body portion 110 may be configured to fit inside a passage in body tissue and/or include a cylindrical shape or any other shape disclosed herein. (FIG. 5). Head portion 108 may consist of one, two, or more tabs which may resist base component 102 from being pulled into and/or through the body tissue. Base component 102 may be configured to a length that will allow sufficient locking relative to elongate member 106. Head portion 108 of base component 102 may be configured to a thickness to resist recession into body tissue. The width and/or length of the tabs may also be configured to resist pulling of base component 102 into and/or through tissue. Any embodiment herein, for example the edges of head portion 108 of base component 102, may be radiused, chamfered, broken, smoothed, ground, or otherwise processed to remove sharpness and/or provide a lead-in.


Body portion 110 of base component 102 may be centrally located or offset to an end (not shown). (FIGS. 5-8). The passage may be centered or offset (not shown) with respect to body portion 110. All or any portion of the cross-sectional shape of body portion 110 may be circular (as shown), triangular, square, rectangular, pentagonal, hexagonal, or any other round or polygonal shape. Embodiments, for example one or more ends, may be radiused, chamfered, broken, smoothed, ground, blunted, or otherwise processed to remove sharpness and/or provide a lead-in.


All or any portion of base component 102 may include a passage. (FIG. 8). The passage may be centrally located and/or may include a taper from an upper end of head portion 108 to a lower end of body portion 110. The cross-sectional shape of the passage may be circular (as shown), triangular, square, rectangular, pentagonal, hexagonal, or any other round or polygon. The passage of any embodiment, for example the upper or lower ends, may be radiused, chamfered, broken, smoothed, ground, or otherwise processed to remove their sharpness and/or provide a lead-in. The surface of the passage of any embodiment may be smooth (shown), textured, notched, ringed, stepped, and/or roughened.


Insert component 104 may include a taper and/or a cross-sectional shape that is circular, triangular, square, rectangular, pentagonal, hexagonal, or any other round or polygon. (FIGS. 9-12). The taper may run from an upper end to a lower end of insert component 104. The taper angle of insert component 104 and base component 102 may be substantially equal or matched. Alternatively, the taper angles of the two components may be different, offset, or opposite. All or any portion of insert component 104 may have no taper (i.e. upper portion of insert component 104), a linear taper (i.e. middle portion of insert component 104), and/or a varying or non-linear taper (i.e. lower portion of insert component 104). (FIG. 10). Any surface or edge of any embodiment herein, for example insert component 104, may be radiused (shown), chamfered, broken, smoothed, ground, or otherwise processed to remove sharpness and/or provide a lead-in.


Insert component 104 may be a solid structure or include a passage through all or any portion of its length. The passage may be centrally located or offset (not shown). (FIGS. 9-12). The passage of insert component 104 may extend through all or a portion (shown) of insert component 104. (FIG. 12). The passage of insert component 104 may be angled with respect to a longitudinal axis of insert component 104. The passage may be smooth, threaded (shown), ringed, undercut, notched, stepped, textured, or drilled. (FIGS. 9, 11, and 12). A lower portion of the passage may be flat or pointed, for example, from a tip of a drill (FIG. 12). The passage of insert component 104 may be configured for insertion and/or removal of insert component 104 relative to body tissue. The passage of insert component 104 may be used as an attachment feature for insertion and/or removal instrumentation. For example, a screw tipped instrument may be driven into the passage of insert component 104 until the instrument contacts the lower portion of the passage of insert component 104, then further rotation of the instrument may rotate insert component 104 thereby allowing it to loosen with respect to elongate member 106 and be removed from the body tissue.


In another embodiment, elongate member 106 may run through the passage in base component 102 and/or insert component 104. (FIGS. 13-16). In use, base component 102 may be urged along elongate member 106 to achieve the desired tension and/or location with respect to the body tissue. Then, insert component 104 may then be positioned over the trailing end of elongate member 106 and urged into base component 102.


A leading end of insert component 104 may be configured to fit into the tapered passage of base component 102. (FIG. 16) Base component 102 and/or insert component 104 may be configured for a press-fit. Alternatively, an externally threaded insert component 104 may screw into an internally threaded base component 102. In use, insert component 104 may be advanced into base component 102 while the leading end of insert component 104 may be forced by the tapered passage of base component 102, thereby pinching elongate member 106 to secure elongate member 106 relative to the body tissue.


All or any portion of the passage of base component 102 may be stepped. (FIGS. 17-24). The lower portion of the passage of base component 102 may include a tapered angle while the upper portion of the passage of base component 102 may include a substantially constant or fixed diameter. The upper portion of the passage of base component 102 (FIGS. 21-24) may be internally threaded to match the external thread on insert component 104 (FIGS. 25-28). Alternatively, the upper portion of the passage of base component 102 and/or the upper portion of insert component 104 may be unthreaded. Base component 102 may include a head portion 108 of increased thickness and/or a radius interposing body portion 110 and head portion 108. (FIGS. 21-24). Head portion 108 of base component 102 may be of increased thickness, for example, to allow more threads and/or greater contact area.


Insert component 104 may include head portion 112 and body portion 114. (FIGS. 25-28). Head portion 112 and/or body portion 114 may be cylindrical (shown) or any other shape disclosed herein. Head portion 108 may include an external thread. The thread may be configured to mate with the internal thread of base component 102. Head portion 108 may also include a recess, for example, configured to receive a drive instrument to screw insert component 104 into base component 102. (FIGS. 25 and 27). The cross-sectional shape of the recess of insert component 104 may be square (shown), triangular, rectangular, pentagonal, hexagonal, or any other curved or polygonal shape to allow insert component 104 to be driven with an instrument. Insert component 104 may include a passage through all or any portion of the length of insert component 104 for the passage of elongate member 106. The passage may be centered or offset (not shown) with respect to a longitudinal axis of insert component 104. (FIG. 28).


Body portion 114 of insert component 104 may be divided into projections that may be interposed by slits. (FIG. 25-36). Body portion 114 may be configured to flex or bend with respect to head portion 112 of the insert. In use, as insert component 104 is urged into base component 102, the tapered passage in base component 102 may drive these projections radially inward to apply a force against the elongate member 106 that is positioned through insert component 104 or between insert component 104 and base component 102. Body portion 114 of insert component 104 may be divided into two, three, four (shown), five, six or more projections. The projections may be of equal or varying spacing, length, and/or width.


The passage of insert component 104 may include a tapered, chamfered, or radiused surface between head portion 112 and body portion 114. (FIG. 32). The taper angle of insert component 104 may substantially match the taper angle of base component 102. The taper angle of insert component 104 with the taper angle of base component 102 may be configured to increase the contact length between insert component 104 and elongate member 106, for example, to improve the locking strength of fixation device 100. In use, the passage of head portion 112 and body portion 114 of insert component 104 may allow the projections of insert component 104 to flex radially inward and collapse, thereby securing elongate member 106 relative to base component 102.


Another embodiment of insert component 104 may be pressed into base component 102 with or without a passage in head portion 112. (FIGS. 29-32). Insert component 104 may or may not have external threads, for example, on head portion 112. The tapered passage between the projections of body portion 114 may extend all or a portion of the distance from base portion 114 of insert component 104. The cross-sectional shape of base portion 114 of insert component 104 may be circular (shown), triangular, square, rectangular, pentagonal, hexagonal, or any other curved or polygonal shape.


Additional embodiments of insert component 104 may have various taper angles and threaded areas. (FIGS. 33-36). The outer surfaces and/or inner surfaces of the projections of body portion 114 may have two or more taper angles, for example, to facilitate insertion into base component 102 and/or improve locking relative to elongate member 106. (FIG. 33). Insert component 104 may have an externally or internally threaded head portion 112. The passage through the projections of body portion 110 may or may not be tapered. The taper may be configured to increase a contact area with elongated member 106, for example, when the projections may be forced radially inward when being driven into a tapered passage in the base component 102.


Base component 102 may have any shape. Base component 102 may have a substantially symmetric or solid head portion 108, for example circular (shown) or any other shape disclosed herein. (FIG. 37). Alternatively, base component 102 may include any number of tabs, for example one, two, three, four (shown), or more. The tabs may have any dimensions or spacing, for example equal (shown), different, or varying. (FIG. 38).


Referring to FIGS. 39-42, one or more fixation devices 100 may be used. Fixation device 100 may include fastener 116. In use, fixation device 100 may be used to secure elongate member 106 to repair a fracture of hard and/or soft tissue 200. Tissue 200 may include tissue 202 and tissue 204, for example including at least two bone fragments. Tissues 202 and 204 may be urged toward each other with a stabilizing instrument, for example a clamp.


To secure tissue 202 and tissue 204 relative to each other, a cutting instrument, for example a cannulated drill device including an inner drill or K-wire disposed in an exterior cutting sleeve, may be urged into and/or through tissues 202 and 204 from a proximal area to a distal area thereby creating a passage. The inner drill or K-wire and exterior cutting sleeve may be interlocked to simultaneously cut through tissues 202 and 204. Alternatively, the inner drill or K-wire may cut through the fragments before or after the outer sleeve cuts through the fragments.


Next, fastener 116 and elongate member 106 may be deployed. The inner k-wire or drill may be removed while the sleeve is positioned through all or any portion of tissues 202 and 204. Fastener 116, for example an anchor, button, deformable fastener, or any other fixation device, may be connected to elongate member 106 then passed through the sleeve to the distal area. Fastener 116 may include a solid, porous, hard, soft, or deformable material or any other material disclosed herein. Fastener 116 may include a metal, plastic, ceramic, woven, biologic, and/or suture material (i.e. polyethylene). Fastener 116 may be of the same material or different than elongate member 106. Fastener 116 may be rigid, flexible, and/or deformable. Fastener 116 may be comprised of a single or one or more components. Fastener 116 may be positioned through the sleeve by pushing fastener 116 with a pushrod or directly urged with a rigid elongate member 106. Fastener 116 may be positioned through all or any portion of the sleeve, tissue 202, tissue 204, and/or soft tissue adjacent tissue 202 and/or 204. Upon positioning of fastener 116, elongate member 106 may be tensioned thereby pulling fastener 116 against the distal area to reduce the fracture. If the fracture is an avulsion fracture with soft tissue attached to a bone fragment, fastener 116 may be positioned through tissues 202, tissue 204, and the soft tissue attached to the tissues 202 and 204. Tensioning elongate member 106 relative to fastener anchor 116 secures tissues 202 and 204 and the attached soft tissue.


Then, proximal portion of elongate member 106 may be secured, for example, with fixation device 100 or with a knot. The sleeve may be removed from the tissues 202 and 204. Base component 102 may be placed over elongate member 106 near the proximal area and urged toward tissue 202. Body portion 110 of base component 102 may be placed into the tissue passage while head portion 108 of base component 102 remains on the surface of tissue 202. Elongate member 106 may be tensioned by the user manually or with a tensioning instrument to keep tissues 202 and 204 compressed. Insert component 104 may be urged into base component 102 while elongate member 106 remains tensioned. After insert component 104 of fixation device 100 is sufficiently secured to base component 102, elongate member 106 may be secured thereby reducing separation of tissues 202 and 204. Any excess length of elongate member material may be cut and/or removed.


With reference to FIGS. 43-45, fixation device 100 may be used in conjunction with other implants, for example one or more plates 118 and/or screws 120. Plates 118 and screws 120 may be used to secure a bone fracture. For example, larger fragments (i.e. hard tissue such as bone) of the fracture may be secured with plate 118 and screws 120 while elongate member 106 and fixation device 100 may be used to reduce separation of and secure smaller fragments (i.e. soft tissue and smaller fragments of hard tissue such as bone). Plate 118 may include one or more holes. One or more fasteners 116 connected to elongate member 106 may be passed through a hole in plate 118. Base component 102 of fixation device 100 may then be positioned on or in plate 118, mechanically interlocked into plate 118, or not used if insert component 104 is configured to mechanically interlock with an attachment feature (i.e a hole or keyed surface) in plate 118. Plate 118 may have additional holes in the top or sides, for example, to position the cannulated drill device. Upon passing fastener 116 through the holes of plate 118, elongate member 106 may be tensioned and secured with insert component 104. Insert component 104 may mechanically interlock with base component 102 or directly into plate 118 without base component 102. One or more fastener 116 may include a solid button configured to toggle (FIG. 44) and/or a soft, flexible, or deformable material (FIG. 45).


Fixation device 100 may be used for any medical application. In an embodiment, one or more fixation device 100 may be used to repair tissue 200 of a femur, for example a lesser trochanter fracture. (FIGS. 46-49). This type of fracture may be referred to as an avulsion fracture with soft tissue attached to the lesser trochanter. For example, one or more holes may be drilled from an anterior area to a posterior area of the femur through a lesser trochanter area where fasteners 116 may be positioned. (FIG. 46). Elongate member 106 may be tensioned and/or fixation devices 100 may be secured at a proximal portion of elongate member 106. (FIG. 47). One or more fasteners 116 may include a solid button configured to toggle (FIG. 48), soft, flexible, or deformable fasteners (FIG. 49), or any combination thereof.


As another embodiment, one or more fixation device 100 may be used to repair a fracture of tissue 200, for example a greater trochanter fracture of the femur. (FIGS. 50-54). This type of fracture may also be referred to as an avulsion fracture with tissue attached to the greater trochanter. Holes may be drilled into and/or through the greater trochanter to the lesser trochanter for placement of one or more fastener 116. (FIGS. 50-51). Elongate member 106 may be tensioned and/or fixation devices 100 may be placed over the greater trochanter to secure the proximal portion of elongate members 106. (FIG. 51) Fasteners 116 may include solid buttons (FIG. 52), soft, flexible, or deformable fasteners (FIG. 53), or any combination thereof.


In a further embodiment, one or more fixation device 100 may be used to repair an avulsion fracture of tissue 200, for example a greater tuberosity of the humerus. (FIGS. 54-57). Fastener 116 may include a soft, flexible, deformable fastener (FIG. 54), solid button (FIG. 55), or a combination thereof. Tissue 202 may include any hard or soft tissue, for example a rotator cuff. Fastener 116 may be connected to elongate member 106 and/or positionable on tissue 202 (i.e. an upper area of the rotator cuff) and/or tissue 206 (i.e. a greater tuberosity fragment). (FIG. 54). Elongate member 106 may be positioned through tissue 202, tissue 204, and/or tissue 206, for example including a fracture and/or humeral head. Fixation device 100 may be connected to elongate member 106 and/or positionable on tissue 204, for example below the fracture on the lateral side of the humerus.


Elongate member 106 may be positioned through a straight or curved passage. Elongate member 106 may be positioned through tissue 202, 204, and/or 206, for example, through the humerus and/or greater tuberosity fracture. (FIG. 56). A curved or bendable awl or drill may be used to create the passage. Fasteners 116, elongate members 106, and/or fixation devices 100 may be integrated into and/or used with plate 118 and screws 120. (FIG. 57). Screws 120A and 120B may secure plate 118 to tissue 204, for example the humerus. Distal anchors 116A and 116B, elongate members 106A and 106B, and fixation devices 116A and 116B may be positionable through tissue 202 (i.e. rotator cuff), tissue 206 (i.e. a greater tuberosity fragment), and/or tissue 204 (i.e. a humeral head), for example, to secure the fragment and avulsed rotator cuff.


In another embodiment, clamp 300 may be configured to align and reduce the fracture of tissue 200 to drill through the tissue 202 and 204, for example bone fragments. (FIGS. 58-59). Clamp 300 may include leading portion 302, hook portion 304, connection 306, elongate portion 308, handle 310, and/or seat 312. Leading portion 302 may be configured to pierce and/or form a passage through tissue 200 and/or include surfaces configured to grasp and/or position tissue 204, fastener 116, and/or elongate member 106. Hook portion 304 may be configured to curve around tissue 200 for positioning of clamp 300 from a proximal area of tissue 202 to a distal area of tissue 204. Connector 306 and elongate portion 308 may include any connection suitable for controlled movement, for example a ratchet, worm gear, cable, or pneumatic connection. Connector 306 may advance along elongate portion 308 to urge tissue 202 and 204 together. Seat 312 may be configured to grasp and/or position tissue 202. Clamp 300 may be configured to receive and guide a drill to create the passage through tissue 200. Clamp 300 may be configured to secure any fractures of the body, for example the lesser trochanter for repair. (FIG. 59). Leading portion 302 may include a forked end, for example, to allow the drill device to pass through tissue 200 and between the forks of the clamp 300.


Fixation device 100, elongate member 106, and/or fastener 116 may be used in conjunction with other implants, for example implant 122 and/or screw 124. Implant 122 may include an intramedullary rod or nail. Implant 122 may be positioned at any location in the body, for example, to repair a fracture of the proximal femur. (FIGS. 60-62). Implant 122 may be secured with screw 124, for example a lag screw. (FIG. 60). Fastener 166 connected to elongate member 106 may be passed through an attachment feature (i.e. hole) in rod 122 and/or secured with fixation device 100 on the surface of tissue 200. (FIGS. 60-61). Implant 122 may also be secured with fixation device 100 connected to elongate member 106 secured to implant 122 and/or with screw 124 or a nail in the hole through which elongate member 106 is passed.


Embodiments may include two or more sets of fasteners 116, elongate members 106, and/or fixation devices 100 in conjunction with implant 122. (FIG. 61). Fasteners 116 and elongate members 106 may be passed through or around implant 122 (FIG. 62). The passages may be straight or curved, for example using a curved or bendable introducer or drill. (FIG. 61).


Embodiments may include introducer 400, for example an awl. (FIGS. 63-65). Introducer 400 may include fastener 116, elongate portion 402, and/or handle 404. Fastener 116 may be releasably attached to and/or positionable with introducer 400. Introducer 400 may include a sharp or pointed leading end and/or be configured to create a passage in tissue 200. Fastener 116 may provide the sharp or pointed leading end for penetrating tissue, be releasably attached at a distal portion of introducer 400, and/or may be removed after passage is created. (FIG. 63). All or any portion of elongate portion 402 and/or handle 404 may include a passage for elongate member 106 and/or fastener 116. Handle 404 may be used to hold introducer 400 while applying pressure toward tissue 200 and/or urging introducer 400 from side to side to advance the leading end of introducer 400 through tissue. Elongate portion 402 may be curved (shown), bendable, flexible, rigid, straight, and/or have one or more curvatures in one or more planes to approximate a tissue passage or access path. Elongate portion 402 and/or handle 404 may be configured to receive or to be used with an introducer or cutting instrument, for example a drill bit, punch, or reamer. All or any portion of elongate portion 402 and/or fastener 116 may include a channel configured to receive elongate member 106 and/or protect elongate member 106 as introducer 400 is advanced into tissue. (FIG. 64).


Fastener 116 may be releasably attached to introducer 400. (FIG. 65) Introducer 400 may include a shaft with a distal portion including a hollow cylindrical shaped attachment feature. Introducer 400 may be configured to mate with a similar shaped cavity in the proximal end of fastener 116. Attachment feature may include a press-fit or threads. Elongate portion 402 and fastener 116 may include attachment features to maintain engagement during positioning. The attachment feature may include a cross-sectional shape that is circular (shown), triangular, square, rectangular, pentagonal, hexagonal, keyed, or any other shape configured to align and secure elongate portion 402 and fastener 116.


Introducer 400 may include pushrod 406. (FIG. 66). Pushrod 406 may be configured to disconnect fastener 116 from elongate portion 402. Pushrod 406 may be urged through the passage in introducer 400. After pushrod 406 is positioned through the passage of introducer 400, a leading end of pushrod 406 may urge fastener 116 away from elongate portion 402. Pushrod 406 may also attach to fastener 116 with an attachment feature, for example a press-fit, threads, or another feature disclosed herein to retain fastener 116. The attachment feature of pushrod 406 may be used in conjunction with or in place the attachment feature of elongate portion 402. Pushrod 406 may be curved, bendable, rigid, straight, and/or have one or more curvatures in one or more planes to accommodate a tissue passage or desired access path.


Fastener 116 may include flexible, bendable, and/or deformable configurations for securing elongate member 106. (FIGS. 67-80). Fastener 116 may be substantially flat and/or woven. Elongate member 106 may pass, slide, and/or be tensioned through all or one or more portions of fastener 116. Embodiments may include any combination of nonwoven, polymer, fabric, sheet, composite, flexible, deformable, hydrophilic, and/or expandable materials. Elongate member 106 may be passed through, along, and/or around fastener 116. In use, as tension is applied to elongate member 106, fastener 116 may contract, deform, bunch, and tighten, for example, to resist being pulled through a body tissue or a hole through which fastener 116 was passed. Fastener 116 may include any cross-sectional shape disclosed herein or any other shapes configured to resist movement of elongate member 106 with respect to tissue.


Elongate member 106 may be positioned through fastener 116 in a limitless number of configurations. Elongate member 106 may pass through fastener 116 with any number of piercing locations, for example one (not shown), two (FIG. 67-68), three (FIGS. 69-72), four (FIGS. 73-78), five (not shown), six (FIGS. 79-80), or any other number of locations. Elongate member 106 may enter and exit from opposite ends and/or faces of fastener 116. (FIGS. 69-70). Elongate member 106 may form a loop through fastener 116 while entering and exiting from the same end and/or opposing faces of fastener 116. (FIGS. 71-72). Elongate member 106 may pass through fastener 116 with four distinct piercing locations and elongate member 106 enters and exits from opposing ends and/or the same face of fastener 116. (FIGS. 73-74). Elongate member 106 may form a loop through fastener 116 while entering and exiting from opposing ends and/or the same face of fastener 116. (FIGS. 75-76). Elongate member 106 may pass through a central portion of fastener 116, form a small loop by passing to one end of fastener 116, form a large loop when passing through the opposing end of fastener 116, form a second small loop, return through the central portion of fastener 116, and/or exit from the same face it entered. (FIGS. 77-78). Elongate member 106 may form five small loops with the two ends exiting on the same face in the central portion of fastener 116. (FIGS. 79-80).


Embodiments may include interlocking components 126, 128, and 130. (FIGS. 81-82). Component 126 may be connected to elongate member 106A. Fastener 116 may include components 128 and 130 and/or be connected to elongate member 106B. Components 128 and 130 may be bendably joint, for example with a hinge, or portions of one continuous component. Elongate members 106A and 106B may be distinct elements or portions of the same elongate member. Component 126 may include a first bore configured to receive elongate member 106A and/or a second bore configured to receive components 128 and/or 130 connected to elongate member 106B. Components 128 and 130 may each include a passage configured receive elongate member 106B. In use, components 128 and 130 connected to elongate member 106B are passed through the second bore while in a first configuration (FIG. 81), then elongate member 106B may be tensioned to reorient components 128 and 130 to a second configuration (FIG. 82). The second configuration of components 128 and 130 may obstruct movement of fastener 116 through the second hole thereby securing elongate member 106B relative to elongate member 106A.


Additional interlocking embodiments are contemplated herein. (FIGS. 83-84). Component 126 may be connected to elongate member 106A. Fastener 116 may be connected to elongate member 106B. Component 126 may include a first bore configured to receive elongate member 106A and/or a second bore configured to receive fastener 116 connected to elongate member 106B. Fastener 116 may include a passage configured receive elongate member 106B. Fastener 116 may include a flexible, bendable, deformable, and/or expandable material. In use, fastener 116 is configured to pass through the bore of component 126 while in a first configuration (FIG. 83), then elongate member 106B may be tensioned to deform fastener 116 to a second configuration (FIG. 84). The second configuration of fastener 116 may obstruct movement of fastener 116 through the second hold thereby securing elongate member 106B relative to elongate member 106A.


Further interlocking embodiments may include smooth surfaces or attachment features to facilitate locking, for example threaded (shown), textured, roughed, and/or ribbed surfaces. (FIGS. 85-86). Fastener 116 may include a pointed leading end configured to penetrate tissue, a loop configured to connect with elongate member 106B, and/or an outer surface with attachment features configured to engage component 126. Component 126 may include a bore with attachment features configured to engage fastener 116. The attachment features of fastener 116 and/or component 126 may be configured to mate or interlock with each other. The outer surface of fastener 116 may create or tap threads into the bore of component 126 or vice versa. In use, fastener 116 may pass into and engage the bore of component 126 thereby locking fastener 116 and component 126 relative to each other.


Interlocking embodiments may also utilize various shapes or materials and/or combine one or more other embodiments disclosed herein. (FIGS. 87-88). Elongate member 106A may be connected to fastener 116A, for example a looped, deformable, woven, and/or substantially flat fastener 116. Alternatively, fastener 116A may be a rigid and/or solid loop and/or be integrated into elongate member 106A. Fastener 116B may include a hook. Fastener 116B may be configured to initially slide over fastener 116A then hook the loop of fastener 116A interlocks with fastener 116A when retracted or tensioned by elongate member 106B.


Embodiments may be used in conjunction with joint replacement 500. (FIGS. 89-91). Embodiments may be used with any joint in the body, for example a knee, hip, shoulder, ankle, toe, elbow, spine, wrist, hand, finger, and foot. Fastener 116 and elongate member 106 may be positioned around (FIG. 89) or through (FIG. 90) all or a portion of tissues 200 (i.e. knee joint) or joint replacement 500 (i.e. knee replacement). Tissue 202, 204, and/or 206 may be any combination of soft and/or hard tissues. Elongate member 106 may be connected to fixation device 100 to secure a fracture of tissues 200, for example an avulsion fracture of the tibial tubercle. Embodiments may include one or more fasteners 116, elongate members 106, and fixation devices 100. (FIG. 90). The passages through and/or around tissues 200 or joint replacement 500 may be curved or straight. Fixation devices 100 and fasteners 116 may also be secured exterior to the soft and/or hard tissues 200 of the joint. (FIG. 89) Fasteners 116 and fixation devices 100 may secure tissues from the outer surfaces covering soft and/or hard tissues. Fasteners 116 and fixation devices 100 may secure bone interosseously and be positioned internal to the joint tissues. (FIG. 90-91). Embodiments may be configured to repair any other joint of the body, for example a greater trochanter fracture near a hip replacement. (FIG. 91).


Further embodiments may be configured to repair tissue 200 of articular surfaces of the body, for example articular cartilage. (FIGS. 92-95). Passages may be created through tissue 200 (i.e. bone) to an articulating surface of a joint. (FIG. 92). Fasteners 116 connected to elongate members 106 may be positioned on the articular surface through the passages. (FIG. 93). Fasteners 116 may be deployed on the articular surface. (FIG. 94). Fasteners 116 may include a woven, mesh, scaffold, collagen, or any other synthetic or biologic material that encourages tissue growth to repair a tissue defect. Fastener 116 may be resorbable or permanent material. Fastener 116 may include any other material disclosed herein. Fasteners 116 may be secured to the articular cartilage surface by the attachment of an elongate member 106 and/or fixation device 100. (FIG. 95).


Embodiments may be configured to repair a defect in a passage with implant 132. (FIGS. 96-101). The passage could be a natural or created passage through all or any portion of a bone, tendon, muscle, organ, blood vessel, and/or any other body tissue. (FIGS. 96-97). Implant 132 may include a mesh, scaffold, collagen, or other synthetic or biologic material that encourages tissue growth. Implant 132 may be positioned with introducer 134, which may be an expandable, inflatable, and/or balloon device. (FIG. 98). Introducer 134 may have a contracted configuration and an expanded configuration. Introducer 134 in the contracted configuration may axially position implant 132 along the passage to the location of the defect. At or near the location of the defect, introducer 134 may expand to the expanded configuration thereby radially expanding implant 132 against the defect. (FIG. 99) Introducer 134 may be radially contracted to the contracted configuration while the expanded implant 132 remains attached to the interior of the passage. (FIG. 100). The attachment may result from a mechanical attachment, mechanical and/or thermal expansion, adhesive, magnetic, ultrasonic activation, swelling, or any other method of adherence and/or expansion. Introducer 134 may be axially retracted from the passage while implant 132 substantially maintains an expanded position against the passage to repair the defect. (FIG. 101). Alternatively, implant 132 may include a biodegradable material configured to degrade and/or absorb after a period of time based on the material selected.


Additional embodiments may include clamp 300 and/or be configured for reduction of a fracture in conjunction with insertion of the fastener 116, elongate member 106, and fixation device 100. (FIGS. 102-109). Clamp 300 may be comprised of a leading portion 302, hook portion 304, connection 306, elongate portion 308, and/or handle 310. (FIG. 102) Hook 304 may be removable and/or replaceable with a hook 304 of a different configuration, for example straight or of a different curvature or radius. Handle 310 may include a locking mechanism 318 such as a set screw, clamp, or other feature configured to release the hook 304 for replacement hook 304 with a different configuration. A distal portion of leading portion 302 of hook 304 may include opening 320 configured to accept a drill and textured region 324 configured to grip bone fragments. Elongate portion 308 may be configured as a passageway for other instrumentation and/or a proximal clamp using connection 306 mating with bore 314 of handle 310. Connection 306 may include an attachment feature to mate with the bore 314 in handle 310, for the attachment feature may include threads, slots, clamps, or any other feature disclosed herein. Connection 306 may include a drive region 322 for an instrument (not shown) to screw the elongate portion 308 down to secure bone. (FIG. 102). Handle 310 may include posts 316 or other attachment features configured for attachment of other instruments or modular assemblies. Attachment features may include threads, clamps, internal bores and/or posts, or any other feature disclosed herein.


Clamp 300 may be positionable around and configured to secure a fracture of tissue 200. (FIG. 103-104). Hook 304 may be configured to wrap around tissues 202 and 204. (FIG. 103-104). Leading portion 302 may be passed along and positioned around tissues 202 and 204, for example bone fragments. Leading portion 302 may be pulled back with or retracted into the handle 310 to reduce the fracture of tissue 200. Elongate portion 308 may be inserted into the threaded bore 314 in the handle and/or connection 306 may engage threads in bore 314. Elongate portion 308 may be driven by an instrument (not shown) until seat 312 contacts tissue 202, which may further reduce the fracture. After elongate portion 308 is positioned with respect to connection 306, the fracture of tissue 200 is reduced and/or secured between seat 312 and leading portion 302 of the hook 304.


Clamp 300 may include drill guide 330 and/or drill assembly 340. (FIGS. 105-106). Drill guide 330 may include shaft 332. Shaft 332 may be configured to be passed into the passage of handle 310 and/or elongate portion 308, for example, until drill guide head 334 fits into slot 326 of handle 310. Drill assembly 340 may be attached to a powered drill (not shown) and/or advanced through handle 310, elongate portion 308, and/or drill guide 330. Drill assembly 340 may include two or more components, for example, including sleeve 342 and drill 346. Sleeve 342 and drill 346 may be secured together, for example, with attachment feature 344 on sleeve 342 and/or attachment feature 348 on drill 346. Attachment features 334 and/or 348 may include a keyed interlock or any other attachment feature disclosed herein. As drill assembly 340 is advanced through tissues 202 and 204, the distal portions of drill 346 and sleeve 342 may exit tissue 204 and/or pass through opening 320 of leading portion 302. After passing through the surface of tissue 304, drill assembly 340 may stop as attachment feature 344 contacts drill guide head 334. A powered drill (not shown) may then be detached from the drill assembly 340.


Then, fastener 116 attached to the elongate member 106 may be positioned (FIG. 107). Drill 346 may be removed by rotating drill 346 to disengage attachment features 344 and 348. Sleeve 342 may be kept in position as the passage therein may be used for inserting fastener 116 and elongate member 106. Fastener 116 and elongate member 106 may be inserted into sleeve 342 and/or pushrod assembly 350 may be configured to advance the fastener 116 and/or elongate member 106 to and/or through the fracture of tissue 200. Shaft 352 of pushrod assembly 350 may be inserted into sleeve 342. Head 354 of the pushrod 350 may be pressed while fastener 116 and elongate member 106 are advanced through sleeve 342 and the fracture of tissue 200 until fastener 116 and elongate member 106 pass out of the sleeve 342 and onto a distal area of tissue 204. After the fastener 106 is deployed, pushrod assembly 350, sleeve 342, and drill guide 330 may be removed.


Fixation device 100 including base component 102 and insert component 104 may be positioned with respect to elongate member 106. (FIG. 108). Base component 102 may be attached to a holder 356 with an end profile configured to receive base component 102. Elongate member 106 may be positioned through the base 102, holder 356, and base component 102 until elongate member 106 is advanced until elongate member 106 reaches the fracture of tissue 200 and/or tissue 202. Insert component 104 may be pressed or threaded onto a distal portion of insert rod 358 and is advanced through the holder 356 positioned on base component 102. Insert rod 358 may include a channel cut along its side for elongate member 106 to pass. Elongate member 106 may be tensioned to remove slack while base component 102 and insert component 104 are positioned at a proximal area of tissue 202.


Clamp 300 may be used in conjunction with instrument 360. (FIG. 109). Instrument 360 may be configured for tensioning and/or deployment of elongate member 106 and/or fastener 116. Instrument 360 may be releasably attachable to clamp 300, for example, by sliding slots 364 of base bracket 362 over posts 316 of handle 310. Instrument 360 may slide onto the handle 310 and around holder 362 and insert rod 358 along top slot 366 of base bracket 362. Instrument 360 may additionally include uprights 370, tensioning rod 380 with knob 384, and press handle 390.


After instrument 360 is positioned and base bracket 362 is secured, press handle 390 may be adjusted to a desired height by rotating press handle 390 so that handle pin 394 may be moved through slots 374 in uprights 370 and into at least one of positioning holes 376. Handle pin 394 may be generally round with flats on two or more sides, for example, to allow it to be moved from positioning hole 376 and into the slot 374 in uprights 370. From slot 374, handle pin 394 may be rotated into alignment with the desired positioning hole 376. Then, handle pin 394 may be passed into the positioning hole 376, thereby locking the position of the press handle 390.


Elongate member 106 which is passed through the holder tube 356 and into a groove in insert rod 358. Insert rod 358 may be passed through the slot 392 in press handle 390 and into slot 382 in tensioning rod 380. After positioning elongate member 106, elongate member 106 may be held in tension until the tensioning rod 380 is rotated by knob 384. As knob 384 is rotated, tension may be applied to elongate member 106 to pull fastener 116 tight to secure tissue 204 of the fracture of tissue 200. Embodiments may include a tensioning mechanism, for example a clutch, ratchet, gear and pawl, spring loaded lock, anti-reversing mechanism, or any other device disclosed herein capable of holding or applying tension. The tensioning mechanism may be integrated into any portion of the device, for example tensioning rod 380, uprights 370, knob 384, and/or knob connection 386. The tensioning mechanism may be configured to apply tension and/or resist a loss of tension in the elongate member 106. The tensioning mechanism may be configured to dial in or pre-set the desired amount of tension for elongate member 106. Embodiments of the present disclosure may include any additional devices and methods disclosed U.S. Patent Application Publication Nos. 2006/0229623, titled “Tissue Fixation System and Method”, 2008/0195145, titled “Tissue Fixation System and Method”, and 2007/0088362, titled “Apparatus and Methods for Surgery”, which are hereby incorporated by reference in their entirety.


After elongate member 106 is tensioned to reduce the fracture, press handle 390 may be squeezed and rotated toward the handle 310. This motion may drive insert rod 358 toward tissue 200, thereby pressing insert component 104 into the base component 102 and/or securing elongate member 106. After the press handle 390 is rotated, the pressure on handle 390 may be released, elongate member 106 in the tensioning rod 380 may be unwrapped or cut, and instrument 360 may be removed. After insert component 104 is pressed into the base component 102 with the elongate member 106 captured therein, insert rod 358 and holder tube 356 can be removed, thereby leaving the fixation device 100 on a proximal area of the tissue 202, fastener 116 on a distal area of tissue 204, and elongate member 106 tensioned and secured therebetween.


In addition to the embodiments of FIGS. 102-109, any instrumentation suitable to secure fixation device 100 to the elongate member 106 and/or to secure two or more tissue fragments may be utilized. Any clamping or comparable mechanism may be employed including an in-line handle and drill guide. Also, a variety of instruments configured for tensioning and deployment may attach to clamp 300 or be standalone.


As another embodiment, fixation device 100 may include a threaded insert component 104 configured to screw into threaded base component 102 to secure the elongate member 106. (FIG. 110). The threaded interface may be entirely or partially disengaged prior to receiving or tensioning elongate member 106, then may engage when elongate member 106 positioned therebetween. The threads may be rounded, dulled, softened, blunted, or otherwise configured to secure the elongate member 106 while minimizing damage to elongate member 106. Alternatively, the threaded interface may be replaced with any attachment features disclosed herein.


Insert 104 may also be threaded at a taper angle that may or may not match a threaded taper of the base component 102. (FIG. 111) The threaded interface may secure elongate member 106. Also, the threads may be configured to act as energy directors to receive energy as an attachment feature, for example including vibratory or thermal energy. Energy may be used to join the base component 102 and insert component 104, for example, to secure the elongate member 106


Another embodiment of fixation device 100 may include a tortuous path to secure elongate member 106. (FIG. 112). Elongate member 106 may be forced into or clamped between a tortuous path between the projections base component 102 and insert component 104. This may also apply friction to elongate member 106 thereby resisting motion. Fixation device 100 could be secured by mechanical interference of the projections, mechanical interlock, Morse taper, vibratory or thermal joining, or any other attachment feature disclosed herein. Embodiments of the present disclosure may include any additional devices and methods disclosed U.S. Pat. No. 6,475,230, titled “Method and Apparatus for Securing a Suture” and U.S. Pat. No. 8,162,977, titled “Method for joining implants”, which are hereby incorporated by reference in their entirety.


Additional embodiments of fixation device 100 may include insert component 104 that may be configured to be driven into the base component 102 with energy, for example vibratory (i.e. ultrasonic) or thermal energy. (FIG. 113). The distal portion of the insert component 104 may be configured to meet the bottom of the undersized and/or tapered bore of the base 102. Insert 104 may be configured to shorten, widen, melt, and/or flow, for example, into the undercut cavities in the base component 102. The melted material may then solidify in the undercut thereby securing insert component 102 to base component 104 while locking the elongate member 106 between the walls of the components.


Embodiments may use energy to bond, assemble, secure, and/or position fixation devices and/or implants. Energy may be applied preoperatively, intraoperatively, or postoperatively. For example, vibratory energy (i.e. ultrasonic energy) may be utilized to bond fixation devices and/or implants (i.e. joint replacements) with respect to a portion of the body. Vibratory energy may be utilized to bond one or more components of the embodiments herein with respect to each other. Embodiments of the present disclosure may include any additional devices and methods disclosed in any of U.S. Pat. No. 7,967,820, titled “Methods and Devices for Trauma Welding” and U.S. Pat. No. 8,162,977, titled “Methods for Joining Implants”, U.S. Patent Application Publication Nos. 2009/0024161, titled “Methods and Devices for Intracorporeal Bonding of Implants with Thermal Energy”, 2010/0211120, titled “Methods and Devices for Utilizing Bondable Materials”, 2012/0316472, titled “Ultrasonic Handpiece”, 2012/0316473, titled “Methods and Systems for Controlling an Ultrasonic Handpiece based on a Sensed Pressure”, 2012/0316474, “Methods and Systems for Controlling an Ultrasonic Handpiece based on Tuning Signals”, and U.S. patent application Ser. No. 13/789,658, titled “Vibratory Energy Systems and Methods for Occluded Body Cavities”, all of which are hereby incorporated by reference in their entirety.


Embodiments may include with a shape memory material. (FIGS. 114-115). For example, leading portion 104B of insert component 104 may include a shape memory portion. Insert component 104 may be pressed into a base component 102. After leading portion 104B is positioned in the passage of base component 102, the shape memory material of leading portion 104B may be activated by force or a change in temperature. Leading portion 104B may expand and/or prevent loosening and/or withdraw of the insert component 104 from base component 102, for example, secure elongate member 106.


Further embodiments may include deformable materials or configurations. (FIGS. 116-118) Fastener 116 may be deformable. Fastener 116 connected to elongate member 106 may be passed through and/or positioned with introducer 402. (FIG. 116). Fastener 116 may include a circular or round shape with one or more elongate member 106 positioned through fastener 116. (FIG. 117). Fastener 116 may be in the shape of a cross or plus sign with tabs. (FIG. 118) The tabs may facilitate folding of fastener 116 into inserter 402. Also, the tabs may be configured to receive two or more elongate members 106.


Additional embodiments may be utilized with implants, for example plates and/or screws. (FIGS. 119-121). Embodiments may be used in conjunction with a proximal humerus fracture plate similar to that shown previously in FIG. 57. Plate 118 may be secured to tissue 200 (i.e. bone) with screws 124. Smaller holes 136 may be located on or near a peripheral portion of plate 118, for example, to receive fasteners 116 attached to elongate members 106. Fasteners 116 may be used to secure tissue 200, for example a rotator cuff. Elongate members 106 may secure tissue 200 by passing through or around tissue 200, for example a humeral head. Elongate members 106 may be secured to plate 118 by insert components 104, for example, by being pressed into holes 136 of plate 118. Holes 136 may be configured to be smaller than holes for traditional screws, for example, to decrease stress concentrations. Also, holes 136 may be located in a peripheral area of plate 118, for example, to be near tissue 200 that requires fixation and to be a distance from the larger screw holes. Also, holes 136 may include a counterbore, for example, to allow for a smaller bore to receive fastener 116 and elongate member 106 while the larger bore configured to receive fixation device 100 or insert component 104 alone. Fixation device 100 or insert component 104 may be pressed into and/or flush with respect to plate 118. Additionally, fixation device 100 or base component 102 can be incorporated into the plate with the counter bore section being threaded for attachment of base component 100 or insert component 104. Hole 136 may also be tapered through all or a portion of its length as an attachment feature for interlocking with the insert 104.


All or any portion of implant 122 may include attachment features. (FIG. 120). Implant 122 may include an intramedullary rod or nail, for example, to provide internal bone fixation. Implant 122 may include holes 138, which may be threaded or include any attachment feature disclosed herein. Implant 122 may also include holes 136 near an end of implant 122 or near a peripheral area of implant 122. One, two, or more holes 138 may be configured to receive fixation device 100 or insert component 102, for example, to secure elongate members 106 connected to fasteners 116. Fasteners 116 may be used for securing tissue fragments that may not be fixated by the traditional intramedullary rods or nails and screws alone.


Implants may include screw 124. Screw 124 may include holes 136 configured to receive fastener 116, elongate member 106, fixation device 100, and/or insert component 104. (FIG. 121) Screw 124 may include head 140 with holes 136 around a peripheral area. Embodiments may include any number of holes 136, for example one, two, three, four, or more holes.


Embodiments may include scaffold or mesh 132. (FIG. 122). Scaffold 132 may include any scaffold or mesh disclosed herein. Scaffold 132 may be incorporated into repair of any portion of the body, for example repair of a humeral head fracture. Scaffold 132 may be configured to promote tissue growth and/or may be secured to the humeral head with fixation devices 100 and/or fasteners 116 connected to elongate members 106. Fasteners 116 and elongate members 106 may be passed through or over tissue 204, 206, and/or 202 (i.e. rotator cuff). This device may secure both soft tissue (i.e. rotator cuff) and hard tissue (i.e. bone). Elongate members 106 pass through the passages created in the humeral head for positioning of the fasteners 116. On the entry side of the passages, fixation devices 100 may secure elongate members 106 and scaffold 132. Scaffold 132 and elongate members 106 may be formed to contour to the tissue surfaces or shrink for improved fixation, for example upon application of energy such as thermal or vibratory energy.


In addition, embodiments may be configured for vascular anastomotic repair. Two tissue segments may be reattached to each other, for example over bone or using a scalpel or balloon. Tissue segments may include tubular, vessel, or anastomotic segments. For example, if an expandable device (i.e. an inflatable device such as a balloon) is positioned to hold the two anastomotic segments in apposition while maintaining the inner diameter, a curved introducer (i.e. awl) may place fastener 116 in a curved section across one vessel segment pulling it around the expandable device or around the scalpel in a curved path back to the second vessel segment, thereby allowing this procedure to tighten and maintain the internal dimension while the expandable device and scalpel are in position. The expandable device (i.e. balloon) may be deflated and the scalpel removed, for example, so the repair occurs around this. Embodiments may be reinforced or sealed with glue adhesive, biofilm adhesive, type adhesive, or any other method disclosed herein. The expandable device and scalpel may maintain the internal dimensions while the outer repair is performed. Embodiments herein may be used in conjunction with the devices and methods disclosed in U.S. Pat. No. 7,497,864, title “Tissue fastener and methods for using same”, which is hereby incorporated by reference in its entirety.


Embodiments may be configured for guidance and/or positioning with energy, for example magnetic energy. Embodiments may include a magnet, electromagnet, and/or magnetizable materials, for example, to position the embodiments herein with a magnetic field. Magnetizable materials include ferrite particles, which may or may not be magnetized. The electromagnet may selectively provide a magnetic field with application of current. The magnetic field may emanate from any portion of the embodiments herein. The magnet, electromagnet, and/or magnetizable materials may be mounted on or included in all or any portion of the embodiments herein. A leading end portion may be utilized to position and/or guide the system. The magnetic field may emanate from a portion of the system or from an external source positioned outside the body. The polarity and/or strength of the magnetic field may be increased, decreased, or alternated to controllably guide the system, for example effector 110. Embodiments of the present disclosure may also include any devices and methods disclosed in U.S. Pat. No. 7,320,319, titled “Medicant Delivery System and Method”, U.S. Patent Application Publication No. 2008/0306324, titled “Magnetic Joint Implant”, and U.S. Pat. No. 6,719,765, titled “Magnetic Suturing System and Method”, which are hereby incorporated by reference in their entirety


Further embodiments may include a robotic system. The robotic system may position fixation devices, for example, by driving them with navigation or imaging devices (i.e. arthroscopic visualization). The robotic system may be configured for repair of tissue fragments. Embodiments may include a robotic arm. The robotic arm may include a robotic mechanism. Embodiments may be configured to position and/or guide any portion of the system. The robotic arm may include a haptic arm. The robotic arm may be automatic, programmed, user controlled, and/or remote controlled. The motion path of the robotic arm may include end points or boundaries, for example, to minimize user error. Embodiments of the present disclosure may also include any devices and methods disclosed in U.S. Patent Application Publication Nos. 2003/0181800, titled “Methods of Securing Body Tissue”, and 2012/0221017, titled “Methods for Robotic Arthroplasty”, which are hereby incorporated by reference in their entirety.


Embodiments may also be positioned with an imaging or guidance device. Imaging devices may be used to directly or indirectly visualize, guide and/or change the orientation or position of embodiments herein. Examples of imaging devices may include endoscopic guidance, computer assisted navigation, magnetic resonance imaging (MRI), CT scan, ultrasound, fluoroscopic, cystoscopy, endoscopic retrograde cholangiopancreatography cystoscopy (ERCP), X-ray, light detectors, metal detectors, magnetic field detectors, electromagnetic devices, or other visualization device disclosed herein. Asymmetric coating, radiopaque markers, or other features identifiable with indirect visualization may be used to identify and/or adjust orientation or position. Indirect visualization may also be used to align portions of a first device relative to a portion of the first device, a second device, or a body portion.


Additional embodiments may be configured to secure and/or stabilize the spine. For example, embodiments may be configured to repair an intervertebral disc herniation. Fixation devices 100, fastener 116, and/or elongate member 106 may be configured to move the disk herniation and repair the annulus. Elongate member 106 may be configured to secure two or more fasteners, rods, or plates relative to each other. Embodiments may be configured to repair soft tissues (i.e. ligaments) to hard tissues (i.e. bone) or be used in conjunction with any other tissues or implants disclosed herein. Embodiments of the present disclosure may include any additional devices and methods disclosed U.S. Patent Application Publication No. 2006/0089646, titled “Devices and Methods for Stabilizing Tissue and Implants”, which is hereby incorporated by reference in its entirety.


Any embodiment herein may be secured using any of the features or methods disclosed herein. For example, base component 102 and insert component 104 may be secured with any internal and/or external attachment features or methods disclosed herein or known in the art. As another example, fixation devices may be integrated into a portion of a plate, independent of a plate, a portion of an implant, screw, or rod. Embodiments may be secured preoperatively, intraoperatively, or postoperatively. Embodiments may be secured with ultrasonic energy, thermal energy, radiofrequency energy, expandable or hydrophilic materials, chemical, electrical, pressure, press-fit, tapered surfaces, threaded surfaces, mechanical or non-mechanical interlocks, or any other attachment feature disclosed herein. Two or more components may be secured with an expandable ring configured to lock two or more components together.


Embodiments may have any material disclosed herein. Embodiments may be all or partially biodegradable. Embodiments may be configured with a portion being a more rigid polymer and another portion being a less rigid polymer. Any portions may be configured to adhere or stick together to resist movement of elongate member 106 (i.e. suture). Embodiments may be configured to allow elongate member 106 to slide when pulled in one direction while resisting motion or disengage elongate member 106 by pulling in the opposite direction. Embodiments may be configured with two components of a similar material but with a different modulus of elasticity, for example to secure elongate member 106 when urged together and to allow elongate member 106 to move when pulled in a first direction but not in a second direction.


One, two or more elongate members 106 may be positioned through an implant, for example a plate, screw, rod, or arthroplasty component. Embodiments may include an angled or flexible configuration. Embodiments may include a curved, smooth, or tapered edge, for example to facilitate introduction and/or minimize soft tissue damage. Embodiments may be introduced in a linear configuration and/or positioned in a non-linear or bent configuration. The implant may have attachment features (i.e. holes) specifically sized and configured for fixation devices. The attachment feature may be recessed and/or adjacent to a plate or rod so the system may be used with traditional screws. To receive a fixation device or elongate member, the attachment feature may be smaller than holes required for traditional screws. This may preserve the mechanical integrity of a plate, screw, or rod, provide improved fixation, and/or allow for fixation to and/or from varying, curved, or nonlinear paths with respect to plates, screw, rods, or other implants. Embodiments may be used to fasten an implant to hard tissue (i.e. bone) or soft tissue to an implant, for example if a ligament is pulled away from a hip or knee implant. As another example, embodiments may be used for reattachment of greater trochanteric tendons. In addition, embodiments of the present disclosure may include all or any portion of the embodiments disclosed in U.S. Pat. No. 7,837,736, titled “Minimally Invasive Surgical Systems and Methods”, which is incorporated herein by reference in its entirety.


All or any portion of any embodiment herein may include any combination of the embodiments disclosed herein. This written description uses examples to disclose various embodiments, which include the best mode, to enable any person skilled in the art to practice those embodiments, including making and using any devices or systems and performing any incorporated methods. The patentable scope is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal languages of the claims.

Claims
  • 1. A fixation system for securing first and second body tissue portions of a fracture, the system comprising: a base component having an aperture, a head portion, and a body portion, wherein the head portion extends at least partially beyond the body portion and is configured to be positioned on an outer surface of the first body tissue, and wherein the body portion has an entirely unthreaded exterior surface and is configured to be positioned in a passage extending through the first and second body tissue portions, and wherein the aperture through the base component has an at least partially tapered inner wall;an insert component positionable within at least a portion of the aperture in the base component, and having an at least partially tapered outer surface;an elongate member configured to be positioned through the passage extending through the first and second body tissue portions and the aperture of the base component, wherein the elongate member is at least one of a suture, wire, and cable; andan anchor configured to couple to the elongate member, the anchor configured to be positioned through the passage extending through the first and second body tissue portions, and the anchor configured to be positioned on the distal outer surface of the second body tissue,wherein the slidably positioned elongate member is substantially maintained against the insert component when the at least partially tapered portion of the insert component is pressed against the at least partially tapered inner wall of the aperture through the base component, deforming a portion of at least one of the base component, insert component, and elongate member to secure the first and second body tissue portions, and wherein the elongate member does not contact with at least one of an internal threaded surface of the body portion of the base component and an external threaded surface of the insert component.
  • 2. The system of claim 1, wherein the base and insert components are pressed together to secure the elongate member.
  • 3. The system of claim 1, wherein an interior bore of the base component and an exterior surface of the insert component are joined together by mating tapered surfaces.
  • 4. The system of claim 1, wherein an interior taper of the base component is configured to match an exterior taper of the insert component to lock the elongate member.
  • 5. The system of claim 1, wherein a taper is disposed between the base component and insert component to promote locking of the elongate member while it is tensioned through the passage and the insert component is pulled into the base component.
  • 6. The system of claim 1, wherein the base component has a cylindrical portion dimensioned to a drilled hole in a proximal bone portion.
  • 7. The system of claim 6, wherein the cylindrical portion provides additional contact length for locking the elongate member.
  • 8. The system of claim 6, wherein the cylindrical portion is configured to minimize the height protruding above a surface of the bone portion.
  • 9. The system of claim 6, wherein the cylindrical portion is configured to stabilize the base and insert components by maintaining a position relative to the hole in body tissue.
  • 10. The system of claim 1, wherein the head portion of the base component includes at least one tab configured to conform to a proximal bone surface and resist the base component from being pulled into a drilled hole on the proximal bone surface.
  • 11. The system of claim 10, wherein the head portion of the base component includes two, three, or more tabs.
  • 12. The system of claim 10, wherein the tab surrounds the perimeter of the head portion of the base component.
  • 13. The system of claim 1, wherein the base component includes a smooth and tapered interior surface.
  • 14. The system of claim 1, wherein the base component includes a tapered distal portion and a threaded proximal interior portion configured to mate with the insert component.
  • 15. The system of claim 1, wherein the insert component includes a passage configured to receive the elongate member and a distal portion configured to pinch the elongate member against the base component.
  • 16. The system of claim 1, wherein the insert component includes threads on a proximal exterior portion for mating with threads in the base component.
  • 17. The system of claim 1, wherein the insert component includes a square, star, or hex shaped recess for screwing the insert component into the base component.
  • 18. The system of claim 1, wherein the insert component includes a recess configured to receive a removal tool for un-screwing the insert component from the base component.
  • 19. The system of claim 1, wherein the insert component includes two or more finger members around a passage through the insert component that are configured to collapse and lock against the elongate member when the insert component is pressed into the base component.
  • 20. The system of claim 1, wherein the insert component includes a tapered exterior configured to press and lock the elongate member between an exterior surface of the insert component and an interior surface of the base component.
  • 21. The system of claim 1, wherein the insert component includes a drilled or tapped passage into a portion of a length of the insert component, the passage being configured to receive a threaded instrument.
  • 22. The system of claim 1, wherein the insert component is configured to be removed from the base component by screwing a threaded tip tool into a passage in the insert component until the tool locks or bottoms in the insert component.
  • 23. The system of claim 22, wherein the insert component is configured to be loosened by rotation of the tool and removed by pulling the tool.
  • 24. The system of claim 1, further comprising a plate or rod.
  • 25. The system of claim 24, wherein the plate or rod includes holes to receive a cannulated drill for making a passage through the fracture.
  • 26. The system of claim 25, wherein the cannulated drill is configured to pass a fastener and elongate member through a cannulated portion of the cannulated drill.
  • 27. The system of claim 24, wherein the plate or rod includes tapered holes configured to allow locking of the elongate member independent of the base component.
  • 28. The system of claim 24, wherein the plate or rod includes holes or cavities.
  • 29. The system of claim 1, wherein the base or insert component includes a metallic, polymer, or resorbable material.
  • 30. The system of claim 29, wherein the metallic material includes stainless steel or titanium.
  • 31. The system of claim 29, wherein the polymer material includes PEEK (polyetheretherketone).
  • 32. The system of claim 1, wherein the base component and insert component are different materials.
  • 33. The system of claim 1, wherein the elongate member includes a metallic material.
  • 34. The system of claim 1, wherein the base component includes metal and the insert component includes PEEK.
CROSS REFERENCE TO RELATED APPLICATIONS

This non-provisional application is based on and claims priority to U.S. Provisional Application No. 61/749,261 filed Jan. 5, 2013, titled “FIXATION DEVICES AND METHODS”, the entire contents of which are hereby expressly incorporated by reference into this disclosure as if set forth fully herein.

US Referenced Citations (875)
Number Name Date Kind
319296 Molesworth Jun 1885 A
668878 Jensen Feb 1901 A
668879 Miller Feb 1901 A
702789 Gibson Jun 1902 A
862712 Collins Aug 1907 A
2121193 Hanicke Dec 1932 A
2187852 Friddle Aug 1936 A
2178840 Lorenian Nov 1939 A
2199025 Conn Apr 1940 A
2235419 Callahan Mar 1941 A
2248054 Becker Jul 1941 A
2270188 Longfellow Jan 1942 A
2518276 Braward Aug 1950 A
2557669 Lloyd Jun 1951 A
2566499 Richter Sep 1951 A
2621653 Briggs Dec 1952 A
2725053 Bambara Nov 1955 A
2830587 Everett Apr 1958 A
3204635 Voss et al. Sep 1965 A
3311110 Singerman Mar 1967 A
3347234 Voss Oct 1967 A
3367809 Soloff Feb 1968 A
3391690 Armao Jul 1968 A
3477429 Sampson Nov 1969 A
3513848 Winston et al. May 1970 A
3518993 Blake Jul 1970 A
3577991 Wilkinson May 1971 A
3596292 Erb et al. Aug 1971 A
3608539 Miller Sep 1971 A
3625220 Engelsher Dec 1971 A
3648705 Lary Mar 1972 A
3653388 Tenckhoff Apr 1972 A
3656476 Swinney Apr 1972 A
3657056 Winston et al. Apr 1972 A
3678980 Gutshall Jul 1972 A
3709218 Halloran Jan 1973 A
3711347 Wagner et al. Jan 1973 A
3760808 Bleuer Sep 1973 A
3788318 Kim et al. Jan 1974 A
3789852 Kim et al. Feb 1974 A
3802438 Wolvek Apr 1974 A
3807394 Attenborough Apr 1974 A
3809075 Matles May 1974 A
3811449 Gravlee et al. May 1974 A
3825010 McDonald Jul 1974 A
3833003 Taricco Sep 1974 A
3835849 McGuire Sep 1974 A
3842824 Neufeld Oct 1974 A
3857396 Hardwick Dec 1974 A
3867932 Huene Feb 1975 A
3875652 Arnold Apr 1975 A
3898992 Balamuth Aug 1975 A
3918442 Nikolaev et al. Nov 1975 A
3968800 Vilasi Jul 1976 A
4023559 Gaskell May 1977 A
4064566 Fletcher et al. Dec 1977 A
4089071 Kainberz et al. May 1978 A
4156574 Boben May 1979 A
4164794 Spector et al. Aug 1979 A
4171544 Hench et al. Oct 1979 A
4183102 Guiset Jan 1980 A
4199864 Ashman Apr 1980 A
4200939 Oser May 1980 A
4210148 Stivala Jul 1980 A
4213816 Morris Jul 1980 A
4235233 Mouwen Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4257411 Cho Mar 1981 A
4265231 Scheller, Jr. et al. May 1981 A
4281649 Derweduwen Aug 1981 A
4291698 Fuchs Sep 1981 A
4309488 Heide et al. Jan 1982 A
4320762 Bentov Mar 1982 A
4351069 Ballintyn et al. Sep 1982 A
4364381 Sher et al. Dec 1982 A
4365356 Broemer et al. Dec 1982 A
4388921 Sutter et al. Jun 1983 A
4395798 McVey Aug 1983 A
4409974 Freedland Oct 1983 A
4414166 Charlson et al. Nov 1983 A
4437191 Van der Zat et al. Mar 1984 A
4437362 Hurst Mar 1984 A
4444180 Schneider et al. Apr 1984 A
4448194 DiGiovanni et al. May 1984 A
4456005 Lichty Jun 1984 A
4461281 Carson Jul 1984 A
4484570 Sutter et al. Nov 1984 A
4493317 Klaue Jan 1985 A
4495664 Bianquaert Jan 1985 A
4501031 McDaniel et al. Feb 1985 A
4504268 Herlitze Mar 1985 A
4506681 Mundell Mar 1985 A
4514125 Stol Apr 1985 A
4526173 Sheehan Jul 1985 A
4532926 O'Holla Aug 1985 A
4535772 Sheehan Aug 1985 A
4547327 Bruins et al. Oct 1985 A
4556350 Bernhardt et al. Dec 1985 A
4566138 Lewis et al. Jan 1986 A
4589868 Dretler May 1986 A
4590928 Hunt et al. May 1986 A
4597379 Kihn et al. Jul 1986 A
4599085 Riess et al. Jul 1986 A
4601893 Cardinal Jul 1986 A
4606335 Wedeen Aug 1986 A
4621640 Mulhollan et al. Nov 1986 A
4630609 Chin Dec 1986 A
4632100 Somers Dec 1986 A
4632101 Freedland Dec 1986 A
4645503 Lin et al. Feb 1987 A
4657460 Bien Apr 1987 A
4659268 Del Mundo et al. Apr 1987 A
4662063 Collins et al. May 1987 A
4662068 Polonsky May 1987 A
4662887 Turner et al. May 1987 A
4669473 Richards et al. Jun 1987 A
4685458 Leckrone Aug 1987 A
4691741 Affa Sep 1987 A
4705040 Mueller et al. Nov 1987 A
4706670 Andersen et al. Nov 1987 A
4708139 Dunbar, IV Nov 1987 A
4713077 Small Dec 1987 A
4716901 Jackson et al. Jan 1988 A
4718909 Brown Jan 1988 A
4722331 Fox Feb 1988 A
4722948 Sanderson Feb 1988 A
4724584 Kasai Feb 1988 A
4738255 Goble et al. Apr 1988 A
4739751 Sapega et al. Apr 1988 A
4741330 Hayhurst May 1988 A
4743257 Tormala May 1988 A
4749585 Greco et al. Jun 1988 A
4750492 Jacobs Jun 1988 A
4768507 Fischell Sep 1988 A
4772286 Goble et al. Sep 1988 A
4776328 Frey et al. Oct 1988 A
4776738 Winston Oct 1988 A
4776851 Bruchman et al. Oct 1988 A
4781182 Purnell et al. Nov 1988 A
4790303 Steffee Dec 1988 A
4792336 Hiavacek et al. Dec 1988 A
4817591 Klause Apr 1989 A
4822224 Carl et al. Apr 1989 A
4823794 Pierce Apr 1989 A
4832025 Coates May 1989 A
4832026 Jones May 1989 A
4834752 Van Kampen May 1989 A
4841960 Garner Jun 1989 A
4843112 Gerhart Jun 1989 A
4846812 Walker et al. Jul 1989 A
4862882 Venturi et al. Sep 1989 A
4869242 Galluzzo Sep 1989 A
4870957 Goble et al. Oct 1989 A
4883048 Purnell et al. Nov 1989 A
4890612 Kensey Jan 1990 A
4895148 Bays et al. Jan 1990 A
4898156 Gatturna et al. Feb 1990 A
4899729 Gill et al. Feb 1990 A
4899744 Fujitsuka et al. Feb 1990 A
4901721 Hakki Feb 1990 A
4921479 Grayzel May 1990 A
4922897 Sapega et al. May 1990 A
4924866 Yoon May 1990 A
4932960 Green et al. Jun 1990 A
4935026 Drews Jun 1990 A
4935028 Drews Jun 1990 A
4945625 Winston Aug 1990 A
4946468 Li Aug 1990 A
4950285 Wilk Aug 1990 A
4954126 Wallsten Sep 1990 A
4955910 Bolesky Sep 1990 A
4957498 Caspari et al. Sep 1990 A
4961741 Hayhurst Oct 1990 A
4963151 Ducheyne et al. Oct 1990 A
4966583 Debbas Oct 1990 A
4968315 Gatturna Nov 1990 A
4968317 Tormala Nov 1990 A
4969888 Scholten et al. Nov 1990 A
4969892 Burton et al. Nov 1990 A
4990161 Kampner Feb 1991 A
4994071 MacGregor Feb 1991 A
4997445 Hodorek Mar 1991 A
4998539 Delsanti Mar 1991 A
5002550 Li Mar 1991 A
5002563 Pyka et al. Mar 1991 A
5009652 Morgan et al. Apr 1991 A
5009663 Broome Apr 1991 A
5009664 Sievers Apr 1991 A
5013316 Goble et al. May 1991 A
5019090 Pinchuk May 1991 A
5021059 Kensey et al. Jun 1991 A
5035713 Friis Jul 1991 A
5037404 Gold et al. Aug 1991 A
5037422 Hayhurst et al. Aug 1991 A
5041093 Chu Aug 1991 A
5041114 Chapman et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047055 Bao et al. Sep 1991 A
5051049 Wills Sep 1991 A
5053046 Janese Oct 1991 A
5053047 Yoon Oct 1991 A
5059193 Kuslich Oct 1991 A
5059206 Winters Oct 1991 A
5061274 Kensey Oct 1991 A
5061286 Lyle Oct 1991 A
5064286 Lyle Oct 1991 A
5069674 Fearnot et al. Dec 1991 A
5078731 Hayhurst Jan 1992 A
5078744 Chvapil Jan 1992 A
5078745 Rhenter et al. Jan 1992 A
5084050 Draenert Jan 1992 A
5084051 Tormala et al. Jan 1992 A
5085660 Lin Feb 1992 A
5085661 Moss Feb 1992 A
5098433 Freedland Mar 1992 A
5098434 Serbousek Mar 1992 A
5098436 Ferrante et al. Mar 1992 A
5100405 McLaren Mar 1992 A
5100417 Cerier et al. Mar 1992 A
5102417 Palmaz Apr 1992 A
5102421 Anspach, Jr. Apr 1992 A
5108399 Eitenmuller et al. Apr 1992 A
5120175 Arbegast et al. Jun 1992 A
5123520 Schmid et al. Jun 1992 A
5123914 Cope Jun 1992 A
5123941 Lauren et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
RE34021 Mueller Aug 1992 E
5141520 Goble et al. Aug 1992 A
5147362 Goble Sep 1992 A
5154720 Trott et al. Oct 1992 A
5156613 Sawyer Oct 1992 A
5156616 Meadows et al. Oct 1992 A
5158566 Pianetti Oct 1992 A
5158934 Ammann et al. Oct 1992 A
5163960 Bonutti Nov 1992 A
5171251 Bregen et al. Dec 1992 A
5176682 Chow Jan 1993 A
5179964 Cook Jan 1993 A
5180385 Sontag Jan 1993 A
5180388 DiCarlo Jan 1993 A
5183464 Dubrul et al. Feb 1993 A
5192287 Fournier et al. Mar 1993 A
5192326 Bao et al. Mar 1993 A
5197166 Meier et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5203784 Ross et al. Apr 1993 A
5203787 Noblitt Apr 1993 A
5208950 Merritt May 1993 A
5209776 Bass et al. May 1993 A
5217493 Raad et al. Jun 1993 A
5219359 McQuilkin et al. Jun 1993 A
5226899 Lee et al. Jul 1993 A
5234006 Eaton et al. Aug 1993 A
5234425 Fogarty et al. Aug 1993 A
5234443 Phan Aug 1993 A
5236438 Wilk Aug 1993 A
5236445 Hayhurst Aug 1993 A
5242902 Murphy et al. Sep 1993 A
5254113 Wilk Oct 1993 A
5258007 Spetzler et al. Nov 1993 A
5258015 Li et al. Nov 1993 A
5258016 DiPoto et al. Nov 1993 A
5261886 Chesterfield Nov 1993 A
5266325 Kuzma et al. Nov 1993 A
5269783 Sander Dec 1993 A
5269785 Bonutti Dec 1993 A
5269809 Hayhurst et al. Dec 1993 A
5281235 Haber et al. Jan 1994 A
5282832 Toso et al. Feb 1994 A
5290281 Tschakaloff Mar 1994 A
5304119 Balaban et al. Apr 1994 A
5306280 Bregen et al. Apr 1994 A
5306301 Graf et al. Apr 1994 A
5315741 Dubberke May 1994 A
5318588 Horzewski et al. Jun 1994 A
5320611 Bonutti et al. Jun 1994 A
5324308 Pierce Jun 1994 A
5328480 Melker et al. Jul 1994 A
5329846 Bonutti Jul 1994 A
5329924 Bonutti Jul 1994 A
5330468 Burkhart Jul 1994 A
5330476 Hiot et al. Jul 1994 A
5330486 Wilk Jul 1994 A
5336231 Adair Aug 1994 A
5336240 Metzler et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5349956 Bonutti Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354298 Lee et al. Oct 1994 A
5354302 Ko Oct 1994 A
5366480 Corriveaau et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370660 Weinstein et al. Dec 1994 A
5372146 Branch Dec 1994 A
5374235 Ahrens Dec 1994 A
5376126 Lin Dec 1994 A
5382254 McGarry et al. Jan 1995 A
5383883 Wilk et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5391173 Wilk Feb 1995 A
5395308 Fox et al. Mar 1995 A
5397311 Walker et al. Mar 1995 A
5400805 Warren Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403348 Bonutti Apr 1995 A
5405359 Pierce Apr 1995 A
5411523 Goble May 1995 A
5413585 Pagedas May 1995 A
5417691 Hayhurst May 1995 A
5417701 Holmes May 1995 A
5417712 Whittaker et al. May 1995 A
5423796 Shikhman et al. Jun 1995 A
5431670 Holmes Jul 1995 A
5439470 Li Aug 1995 A
5441538 Bonutti Aug 1995 A
5443512 Parr et al. Aug 1995 A
5447503 Miller Sep 1995 A
5449372 Schmaltz et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5451235 Lock Sep 1995 A
5453090 Martinez et al. Sep 1995 A
5456722 McLeod et al. Oct 1995 A
5458653 Davison Oct 1995 A
5462561 Voda Oct 1995 A
5464424 O'Don Nov 1995 A
5464426 Bonutti Nov 1995 A
5464427 Curtis et al. Nov 1995 A
5470337 Moss Nov 1995 A
5472444 Huebner et al. Dec 1995 A
5474554 Ku Dec 1995 A
5478351 Meade et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5480403 Lee et al. Jan 1996 A
5486197 Le et al. Jan 1996 A
5487844 Fujita Jan 1996 A
5488958 Topel et al. Feb 1996 A
5496292 Burnham Mar 1996 A
5496318 Howland Mar 1996 A
5496335 Thomason et al. Mar 1996 A
5496348 Bonutti Mar 1996 A
5500000 Feagin et al. Mar 1996 A
5501700 Hirata Mar 1996 A
5504977 Weppner Apr 1996 A
5505735 Li Apr 1996 A
5507754 Green et al. Apr 1996 A
5522844 Johnson Jun 1996 A
5522845 Wenstrom, Jr. Jun 1996 A
5522846 Bonutti Jun 1996 A
5527341 Gogolewski et al. Jun 1996 A
5527342 Pietrzak et al. Jun 1996 A
5527343 Bonutti Jun 1996 A
5529075 Clark Jun 1996 A
5531759 Kensey et al. Jul 1996 A
5534012 Bonutti Jul 1996 A
5534028 Bao et al. Jul 1996 A
5540718 Bartlett Jul 1996 A
5542423 Bonutti Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5545206 Carson Aug 1996 A
5549630 Bonutti Aug 1996 A
5549631 Bonutti Aug 1996 A
5556402 Xu Sep 1996 A
5569252 Justin et al. Oct 1996 A
5569305 Bonutti Oct 1996 A
5569306 Thal Oct 1996 A
5573517 Bonutti et al. Nov 1996 A
5573538 Laboureau Nov 1996 A
5573542 Stevens Nov 1996 A
5575801 Habermeyer Nov 1996 A
5578046 Liu Nov 1996 A
5580344 Hasson Dec 1996 A
5584835 Greenfield Dec 1996 A
5584839 Gieringer Dec 1996 A
5584860 Goble et al. Dec 1996 A
5584862 Bonutti Dec 1996 A
5591206 Moufarrege Jan 1997 A
5593422 Muijs Van De Moer et al. Jan 1997 A
5593425 Bonutti et al. Jan 1997 A
5593625 Riebel et al. Jan 1997 A
5601557 Hayhurst Feb 1997 A
5601558 Torrie et al. Feb 1997 A
5601595 Schwartz Feb 1997 A
5607427 Tschakaloff Mar 1997 A
5609595 Pennig Mar 1997 A
5618314 Harwin et al. Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5626612 Bartlett May 1997 A
5626614 Hart May 1997 A
5626718 Philippe et al. May 1997 A
5630824 Hart May 1997 A
5634926 Jobe Jun 1997 A
5628751 Sander et al. Jul 1997 A
5643274 Sander et al. Jul 1997 A
5643293 Kogasaka et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643321 McDevitt Jul 1997 A
5645553 Kolesa et al. Jul 1997 A
5645597 Krapiva Jul 1997 A
5645599 Samani Jul 1997 A
5649955 Hashimoto et al. Jul 1997 A
5649963 McDevitt Jul 1997 A
5651377 O'Donnell, Jr. Jul 1997 A
5658313 Thal Aug 1997 A
5660225 Saffran Aug 1997 A
5662658 Wenstrom, Jr. Sep 1997 A
5665089 Dall et al. Sep 1997 A
5665109 Yoon Sep 1997 A
5667513 Torrie et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5674240 Bonutti Oct 1997 A
5681310 Yuan et al. Oct 1997 A
5681333 Burkhart et al. Oct 1997 A
5681351 Jamiolkowski et al. Oct 1997 A
5681352 Clancy, III et al. Oct 1997 A
5685820 Riek et al. Nov 1997 A
5688283 Knapp Nov 1997 A
5690654 Ovil Nov 1997 A
5690655 Hart et al. Nov 1997 A
5690676 DiPoto et al. Nov 1997 A
5693055 Zahiri et al. Dec 1997 A
5697950 Fucci et al. Dec 1997 A
5702397 Gonle et al. Dec 1997 A
5702462 Oberlander Dec 1997 A
5707395 Li Jan 1998 A
5713903 Sander et al. Feb 1998 A
5713921 Bonutti Feb 1998 A
5718717 Bonutti Feb 1998 A
5720747 Burke Feb 1998 A
5725541 Anspach, III et al. Mar 1998 A
5725556 Moser et al. Mar 1998 A
5725582 Bevan Mar 1998 A
5730747 Ek et al. Mar 1998 A
5733306 Bonutti Mar 1998 A
5720753 Sander et al. Apr 1998 A
5735875 Bonutti et al. Apr 1998 A
5735877 Pagedas Apr 1998 A
5735899 Schwartz et al. Apr 1998 A
5741282 Anspach, III et al. Apr 1998 A
5752952 Adamson May 1998 A
5752974 Rhee et al. May 1998 A
5755809 Cohen et al. May 1998 A
5762458 Wang et al. Jun 1998 A
5766221 Benderev et al. Jun 1998 A
5769894 Ferragamo Jun 1998 A
5772672 Toy et al. Jun 1998 A
5776151 Chan Jul 1998 A
5779706 Tschakaloff Jul 1998 A
5782862 Bonutti Jul 1998 A
5785713 Jobe Jul 1998 A
5792096 Rentmeester et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5800537 Bell Sep 1998 A
5807403 Beyar et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810853 Yoon Sep 1998 A
5810884 Kim Sep 1998 A
5814072 Bonutti Sep 1998 A
5814073 Bonutti Sep 1998 A
5817107 Schaller Oct 1998 A
5823994 Sharkey et al. Oct 1998 A
5824009 Fukuda et al. Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836897 Sakural et al. Nov 1998 A
5839899 Robinson Nov 1998 A
5843084 Hart Dec 1998 A
5843178 Vanney et al. Dec 1998 A
5845645 Bonutti Dec 1998 A
5851185 Berns Dec 1998 A
5865834 McGuire Feb 1999 A
5866634 Tokushige Feb 1999 A
5868749 Reed Feb 1999 A
5874235 Chan Feb 1999 A
5879372 Bartlett Mar 1999 A
5891166 Schervinsky Apr 1999 A
5891168 Thal Apr 1999 A
5893880 Egan et al. Apr 1999 A
5897574 Bonutti Apr 1999 A
5899911 Carter May 1999 A
5899921 Caspari et al. May 1999 A
5906579 Vander Salm et al. May 1999 A
5906625 Bito et al. May 1999 A
5908429 Yoon Jun 1999 A
5911721 Nicholson et al. Jun 1999 A
5918604 Whelan Jul 1999 A
5919193 Slavitt Jul 1999 A
5919194 Anderson Jul 1999 A
5919208 Valenti Jul 1999 A
5919215 Wiklund et al. Jul 1999 A
5921986 Bonutti Jul 1999 A
5925064 Meyers et al. Jul 1999 A
5928244 Tovey et al. Jul 1999 A
5928267 Bonutti et al. Jul 1999 A
5931838 Vito Aug 1999 A
5931869 Boucher et al. Aug 1999 A
5940942 Fong Aug 1999 A
5941900 Bonutti Aug 1999 A
5941901 Egan Aug 1999 A
5944750 Tanner Aug 1999 A
5945002 Bonutti Sep 1999 A
5947982 Duran Sep 1999 A
5948000 Larsen et al. Sep 1999 A
5948001 Larsen Sep 1999 A
5951590 Goldfarb Sep 1999 A
5957953 DiPoto et al. Sep 1999 A
5961499 Bonutti Oct 1999 A
5961521 Roger Oct 1999 A
5961554 Janson et al. Oct 1999 A
5964765 Fenton, Jr. et al. Oct 1999 A
5964769 Wagner et al. Oct 1999 A
5968046 Castleman Oct 1999 A
5968047 Reed Oct 1999 A
5948002 Bonutti Nov 1999 A
5980520 Vancaillie Nov 1999 A
5980559 Bonutti Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
5989282 Bonutti Nov 1999 A
5993458 Vaitekunas et al. Nov 1999 A
5993477 Vaitekunas et al. Nov 1999 A
6007567 Bonutti Dec 1999 A
6007580 Lehto et al. Dec 1999 A
6010525 Bonutti et al. Jan 2000 A
6010526 Sandstrom et al. Jan 2000 A
6017321 Boone Jan 2000 A
6033429 Magovern Mar 2000 A
6033430 Bonutti Mar 2000 A
6045551 Bonutti Apr 2000 A
6050998 Fletcher et al. Apr 2000 A
6056751 Fenton, Jr. May 2000 A
6056772 Bonutti May 2000 A
6056773 Bonutti May 2000 A
6059797 Mears May 2000 A
6059817 Bonutti et al. May 2000 A
6059827 Fenton May 2000 A
6063095 Wang et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6066160 Colvin et al. May 2000 A
6066166 Bischoff et al. May 2000 A
6068637 Popov et al. May 2000 A
6068648 Cole May 2000 A
6077277 Mollenauer et al. Jun 2000 A
6077292 Bonutti Jun 2000 A
6080161 Eaves, III et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6086593 Bonutti Jul 2000 A
6086608 Ek et al. Jul 2000 A
6090072 Kratoska et al. Jul 2000 A
6099531 Bonutti Aug 2000 A
6099537 Sugai et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6099552 Adams Aug 2000 A
6102850 Wang et al. Aug 2000 A
6106545 Egan Aug 2000 A
6117160 Bonutti Sep 2000 A
6120536 Ding et al. Sep 2000 A
6125574 Ganaja et al. Oct 2000 A
6126677 Ganaja et al. Oct 2000 A
6139320 Hahn Oct 2000 A
RE36974 Bonutti Nov 2000 E
6149669 Li Nov 2000 A
6152949 Bonutti Nov 2000 A
6155756 Mericle et al. Dec 2000 A
6159224 Yoon Dec 2000 A
6159234 Bonutti et al. Dec 2000 A
6171299 Bonutti Jan 2001 B1
6171307 Bonutti Jan 2001 B1
6174324 Egan et al. Jan 2001 B1
6179840 Bowman Jan 2001 B1
6179850 Goradia Jan 2001 B1
6187008 Hamman Feb 2001 B1
6190400 Van De Moer et al. Feb 2001 B1
6190401 Green Feb 2001 B1
6200322 Branch et al. Mar 2001 B1
6217591 Egan et al. Apr 2001 B1
6224593 Ryan May 2001 B1
6224630 Bao et al. May 2001 B1
6228086 Wahl et al. May 2001 B1
6231592 Bonutti et al. May 2001 B1
6238395 Bonutti May 2001 B1
6238396 Bonutti May 2001 B1
6258091 Sevrain et al. Jul 2001 B1
6264675 Brotz Jul 2001 B1
6267761 Ryan Jul 2001 B1
6273717 Hahn et al. Aug 2001 B1
6280474 Cassidy et al. Aug 2001 B1
6286746 Egan et al. Sep 2001 B1
6287325 Bonutti Sep 2001 B1
6293961 Schwartz et al. Sep 2001 B2
6306159 Schwartz et al. Oct 2001 B1
6309405 Bonutti Oct 2001 B1
6312448 Bonutti Nov 2001 B1
6338730 Bonutti et al. Jan 2002 B1
6340365 Dittrich et al. Jan 2002 B2
6348056 Bates et al. Feb 2002 B1
6358271 Egan et al. Mar 2002 B1
6364897 Bonutti Apr 2002 B1
6368325 McKinley et al. Apr 2002 B1
6368343 Bonutti et al. Apr 2002 B1
6371957 Amrein et al. Apr 2002 B1
6409742 Fulton, III Jun 2002 B1
6409743 Fenton, Jr. Jun 2002 B1
6419704 Ferree Jul 2002 B1
6423088 Fenton Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6428562 Bonutti Aug 2002 B2
6432115 Mollenauer et al. Aug 2002 B1
6447516 Bonutti Sep 2002 B1
6450985 Schoelling et al. Sep 2002 B1
6461360 Adam Oct 2002 B1
6468293 Bonutti et al. Oct 2002 B2
6475230 Bonutti Nov 2002 B1
6488196 Fenton Dec 2002 B1
6500195 Bonutti Dec 2002 B2
6503259 Huxel et al. Jan 2003 B2
6530933 Yeung et al. Mar 2003 B1
6535764 Imran et al. Mar 2003 B2
6544267 Cole et al. Apr 2003 B1
6545390 Hahn et al. Apr 2003 B1
6547792 Tsuji et al. Apr 2003 B1
6551304 Whalen et al. Apr 2003 B1
6551343 Tormala Apr 2003 B1
6554852 Oberlander Apr 2003 B1
6527774 Lieberman May 2003 B2
6558390 Cragg May 2003 B2
6568313 Fukui et al. May 2003 B2
6569187 Bonutti May 2003 B1
6572635 Bonutti Jun 2003 B1
D477776 Pontaoe Jul 2003 S
6557426 Reinemann et al. Jul 2003 B2
6585750 Bonutti Jul 2003 B2
6592609 Bonutti Jul 2003 B1
6594517 Nevo Jul 2003 B1
6585764 Wright et al. Aug 2003 B2
6602293 Bierman Aug 2003 B1
6610080 Morgan Aug 2003 B2
6605090 Trieu et al. Sep 2003 B1
6618910 Pontaoe Sep 2003 B1
6623487 Goshert Sep 2003 B1
6626944 Taylor Sep 2003 B1
6623486 Weaver Oct 2003 B1
6632245 Kim Oct 2003 B2
6635073 Bonutti Oct 2003 B2
6638279 Bonutti Oct 2003 B2
6641592 Sauer et al. Nov 2003 B1
6645227 Fallin et al. Nov 2003 B2
6666877 Morgan et al. Dec 2003 B2
6669705 Westhaver et al. Dec 2003 B2
6679888 Green et al. Jan 2004 B2
6685750 Plos et al. Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6702821 Bonutti Mar 2004 B2
6705179 Mohtasham Mar 2004 B1
6709457 Otte Mar 2004 B1
6719765 Bonutti Apr 2004 B2
6719795 Cornwall Apr 2004 B1
6719797 Ferree Apr 2004 B1
6722552 Fenton Apr 2004 B2
6733531 Trieu May 2004 B1
6764514 Li et al. Jul 2004 B1
6770078 Bonutti Aug 2004 B2
6780198 Gregoire et al. Aug 2004 B1
6786989 Torriani et al. Sep 2004 B2
6796003 Marvel Sep 2004 B1
6818010 Eichhorn et al. Nov 2004 B2
6823871 Schmieding Nov 2004 B2
6830589 Erickson Dec 2004 B2
6860885 Bonutti Mar 2005 B2
6878167 Ferree Apr 2005 B2
6893434 Fenton et al. May 2005 B2
6899722 Bonutti May 2005 B2
6890334 Brace et al. Jul 2005 B2
6913666 Aeschlimann et al. Jul 2005 B1
6916321 TenHuisen Jul 2005 B2
6921264 Mayer et al. Jul 2005 B2
6923824 Morgan et al. Aug 2005 B2
6932835 Bonutti Aug 2005 B2
6942684 Bonutti Sep 2005 B2
6944111 Nakamura et al. Sep 2005 B2
6955540 Mayer et al. Oct 2005 B2
6955683 Bonutti Oct 2005 B2
6958077 Suddaby Oct 2005 B2
6981983 Rosenblatt et al. Jan 2006 B1
6997940 Bonutti Feb 2006 B2
7001411 Dean Feb 2006 B1
7004959 Bonutti Feb 2006 B2
7008226 Mayer et al. Mar 2006 B2
7033379 Peterson Apr 2006 B2
7048755 Bonutti May 2006 B2
7066960 Dickman Jun 2006 B1
7087073 Bonutti Aug 2006 B2
7090111 Egan et al. Aug 2006 B2
7094251 Bonutti Aug 2006 B2
7104996 Bonutti Sep 2006 B2
7128763 Blatt Oct 2006 B1
7018380 Cole Dec 2006 B2
7147652 Bonutti et al. Dec 2006 B2
7160405 Aeschlimann et al. Jan 2007 B2
7179259 Gibbs Feb 2007 B1
7192448 Ferree Mar 2007 B2
7217279 Reese May 2007 B2
7217290 Bonutti May 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7250051 Francischelli Jul 2007 B2
7252685 Bindseil et al. Aug 2007 B2
7273497 Ferree Sep 2007 B2
7326200 Trieu Feb 2008 B2
7329263 Bonutti Feb 2008 B2
7335205 Aeshcliamann Feb 2008 B2
7429266 Bonutti Sep 2008 B2
7445634 Trieu Nov 2008 B2
7481825 Bonutti Jan 2009 B2
7481831 Bonutti Jan 2009 B2
7510895 Rateman Mar 2009 B2
7597705 Forsberg et al. Oct 2009 B2
7854750 Bonutti Dec 2010 B2
7879072 Bonutti Feb 2011 B2
7891691 Bearey Feb 2011 B2
7967820 Bonutti Jun 2011 B2
8128669 Bonutti Mar 2012 B2
8140982 Hamilton, II et al. Mar 2012 B2
8147514 Bonutti Apr 2012 B2
8162977 Bonutti et al. Apr 2012 B2
8487844 Koyama Jul 2013 B2
8771314 Crombie Jul 2014 B2
8845699 Bonutti Sep 2014 B2
20010002440 Bonutti May 2001 A1
20010008971 Schwartz Jul 2001 A1
20010009250 Herman et al. Jul 2001 A1
20010041916 Bonutti Nov 2001 A1
20010056287 Bonutti Dec 2001 A1
20020016593 Hearn et al. Feb 2002 A1
20020016633 Lin et al. Feb 2002 A1
20020019649 Sikora Feb 2002 A1
20020026244 Trieu Feb 2002 A1
20020029067 Bonutti Mar 2002 A1
20020029083 Zucherman et al. Mar 2002 A1
20020029084 Paul et al. Mar 2002 A1
20020045902 Bonutti Apr 2002 A1
20020058966 Tormala May 2002 A1
20020062153 Paul et al. May 2002 A1
20020087189 Bonutti Jul 2002 A1
20020103495 Cole Aug 2002 A1
20020120269 Lange Aug 2002 A1
20020123750 Eisermann et al. Sep 2002 A1
20020161439 Strobel Oct 2002 A1
20020183762 Anderson et al. Dec 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20030039196 Nakamura et al. Feb 2003 A1
20030040758 Wang et al. Feb 2003 A1
20030065361 Dreyfuss Apr 2003 A1
20030083667 Ralph May 2003 A1
20030097148 Valimaa May 2003 A1
20030105474 Bonutti Jun 2003 A1
20030118518 Hahn et al. Jun 2003 A1
20030125749 Yuan Jul 2003 A1
20030158555 Sanders Aug 2003 A1
20030158582 Bonutti et al. Aug 2003 A1
20030167072 Oberlander Aug 2003 A1
20030181800 Bonutti Sep 2003 A1
20030195514 Trieu Oct 2003 A1
20030195530 Thill Oct 2003 A1
20030195565 Bonutti Oct 2003 A1
20030204204 Bonutti Oct 2003 A1
20030208203 Lim Nov 2003 A1
20030216742 Wetzler et al. Nov 2003 A1
20030225438 Bonutti et al. Dec 2003 A1
20030229361 Jackson Dec 2003 A1
20040010287 Bonutti Jan 2004 A1
20040024459 Ferree Feb 2004 A1
20040030341 Aeschlimann et al. Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040039392 Trieu Feb 2004 A1
20040220616 Bonutti Feb 2004 A1
20040230223 Bonutti Feb 2004 A1
20040049207 Goldfarb Mar 2004 A1
20040097939 Bonutti May 2004 A1
20040098050 Foerster et al. May 2004 A1
20040102788 Huebner May 2004 A1
20040116963 Lattouf Jun 2004 A1
20040138703 Alleyne Jul 2004 A1
20040138705 Heino Jul 2004 A1
20040143334 Ferree Jul 2004 A1
20040167548 Bonutti Aug 2004 A1
20040172063 Li Sep 2004 A1
20040186471 Trieu Sep 2004 A1
20040225325 Bonutti Nov 2004 A1
20040236374 Bonutti et al. Nov 2004 A1
20050033362 Grafton Feb 2005 A1
20050033366 Cole Feb 2005 A1
20050038514 Helm et al. Feb 2005 A1
20050043733 Eisermann Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050070765 Abdelgany Mar 2005 A1
20050071012 Serhan et al. Mar 2005 A1
20050075644 DiPoto Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050096699 Wixey et al. May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050125072 Kolb Jun 2005 A1
20050126680 Aeschlimann et al. Jun 2005 A1
20050143826 Zucherman et al. Jun 2005 A1
20050240227 Bonutti Jun 2005 A1
20050149024 Ferrante et al. Jul 2005 A1
20050149029 Bonutti Jul 2005 A1
20050203521 Bonutti Sep 2005 A1
20050216059 Bonutti Sep 2005 A1
20050216087 Zucherman et al. Sep 2005 A1
20050222620 Bonutti Oct 2005 A1
20050234460 Miller Oct 2005 A1
20050240190 Gall et al. Oct 2005 A1
20050246021 Ringeisen et al. Nov 2005 A1
20050256582 Ferree Nov 2005 A1
20050261684 Shaolian et al. Nov 2005 A1
20050267481 Carl et al. Dec 2005 A1
20050267534 Bonutti Dec 2005 A1
20050283246 Cauthen Dec 2005 A1
20060009846 Trieu Jan 2006 A1
20060009855 Goble et al. Jan 2006 A1
20060015101 Warburton et al. Jan 2006 A1
20060015108 Bonutti Jan 2006 A1
20060024357 Carpenter et al. Feb 2006 A1
20060026244 Watson Feb 2006 A1
20060142799 Bonutti Feb 2006 A1
20060200199 Bonutti Feb 2006 A1
20060229623 Bonutti Feb 2006 A1
20060064095 Senn et al. Mar 2006 A1
20060167495 Bonutti Mar 2006 A1
20060089646 Bonutti Apr 2006 A1
20060122600 Cole Jun 2006 A1
20060122704 Vresilovic et al. Jun 2006 A1
20060235470 Bonutti Jul 2006 A1
20060241695 Bonutti Jul 2006 A1
20060265009 Bonutti Jul 2006 A1
20060265011 Bonutti Jul 2006 A1
20060189982 Lange Aug 2006 A1
20060212073 Bonutti Sep 2006 A1
20060217765 Bonutti Sep 2006 A1
20060235413 Denham Oct 2006 A1
20060264953 Falahee Nov 2006 A1
20070032825 Bonutti et al. Feb 2007 A1
20070088362 Bonutti et al. Apr 2007 A1
20070118129 Fraser et al. May 2007 A1
20070198555 Friedman et al. Aug 2007 A1
20070233092 Falahee Oct 2007 A1
20070265561 Yeung Nov 2007 A1
20070270833 Bonutti Nov 2007 A1
20080021474 Bonutti et al. Jan 2008 A1
20080039845 Bonutti Feb 2008 A1
20080039873 Bonutti Feb 2008 A1
20080046090 Paul et al. Feb 2008 A1
20080195145 Bonutti Feb 2008 A1
20080097448 Binder et al. Apr 2008 A1
20080108897 Bonutti et al. May 2008 A1
20080108916 Bonutti May 2008 A1
20080114399 Bonutti May 2008 A1
20080132950 Lange Jun 2008 A1
20080140116 Bonutti Jun 2008 A1
20080140117 Bonutti Jun 2008 A1
20080269753 Cannestra Oct 2008 A1
20080269808 Gall et al. Oct 2008 A1
20080288070 Lo Nov 2008 A1
20090024161 Bonutti Jan 2009 A1
20090138014 Bonutti Jan 2009 A1
20090093684 Schorer Apr 2009 A1
20090194969 Bearey Aug 2009 A1
20100211120 Bonutti Feb 2010 A1
20100262185 Gelfand Oct 2010 A1
20110060375 Bonutti Mar 2011 A1
20110295253 Bonutti et al. Dec 2011 A1
20120130492 Eggli May 2012 A1
20120165841 Bonutti Jun 2012 A1
20120191140 Bonutti Jul 2012 A1
20120215233 Bonutti et al. Aug 2012 A1
Foreign Referenced Citations (43)
Number Date Country
2641580 Aug 2007 CA
2680827 Sep 2008 CA
2698057 Mar 2009 CA
1903016 Oct 1964 DE
1903316 Oct 1964 DE
1903016 Aug 1970 DE
3517204 Nov 1986 DE
3722538 Jan 1989 DE
9002844 Jan 1991 DE
784454 May 1996 EP
773004 May 1997 EP
1614525 Jan 2006 EP
1988837 Aug 2007 EP
2134294 Dec 2009 EP
2717368 Mar 1994 FR
2696338 Apr 1994 FR
2728779 Jan 1995 FR
2736257 Jul 1995 FR
2750031 Jun 1996 FR
2771621 Nov 1997 FR
2785171 Oct 1998 FR
2093701 Sep 1982 GB
2306110 Apr 1997 GB
8140982 Jun 1996 JP
184396 Jul 1966 SU
9112779 Sep 1991 WO
9323094 Nov 1993 WO
WO1994008642 Apr 1994 WO
9516398 Jun 1995 WO
WO 9531941 Nov 1995 WO
WO1996014802 May 1996 WO
WO1997012779 Apr 1997 WO
9749347 Dec 1997 WO
WO 9749347 Dec 1997 WO
WO1998011838 Mar 1998 WO
WO1998026720 Jun 1998 WO
WO2002053011 Jul 2002 WO
2007092869 Aug 2007 WO
2007092869 Aug 2007 WO
2008116203 Sep 2008 WO
2009029908 Mar 2009 WO
2009124215 Oct 2009 WO
WO2010099222 Feb 2010 WO
Non-Patent Literature Citations (89)
Entry
Copending U.S. Appl. No. 11/932,907—RCE Response dated Sep. 15, 2011.
Copending U.S. Appl. No. 11/258,795 Non-Final Office Action dated Apr. 26, 2011.
Copending U.S. Appl. No. 11/689,670, RCE Response dated Sep. 19, 2011.
European Search Report dated Sep. 10, 2012 for EP08732724.3.
Copending U.S. Appl. No. 10/614,352, Final Office Action dated Jul. 12, 2010.
Copending U.S. Appl. No. 11/932,602 Final Response to Office Action dated Jun. 10, 2011.
Copending U.S. Appl. No. 11/671,556 Response filed Aug. 23, 2010.
Co-pending U.S. Appl. No. 11/438,537, Supplemental Final Rejection dated Sep. 25, 2009.
Arthrex, Protect your graft, Am J Sports Med, vol. 22, No. 4, Jul.-Aug. 1994.
Barrett et al, T-Fix endoscopic meniscal repair: technique and approach to different types of tears, Apr. 1995, Arthroscopy vol. 11 No. 2 p. 245-51.
Cope, Suture Anchor for Visceral Drainage, AJR, vol. 148 p. 160-162, Jan. 1986.
Gabriel, Arthroscopic Fixation Devices, Wiley Enc. of Biomed Eng., 2006.
Innovasive, We've got you covered, Am J Sports Med, vol. 26, No. 1, Jan.-Feb. 1998.
510k—TranSet Fracture Fixation System, Feb. 24, 2004, k033717.
510k—Linvatec Biomaterials modification of Duet and impact Suture Anchor, Nov. 19, 2004, k042966.
510k, arthrex pushlock, Jun. 29, 2005, K051219.
510k, mitek micro anchor, Nov. 6, 1996, K962511.
510k, Multitak Suture System, Jan. 10, 1997, K964324.
510k, Modified Mitek 3.5mm Absorbable Suture Anchor System, Jun. 9, 1997, K970896.
510K, Summary for Arthrex Inc.'s Bio-Interference Screw, Jul. 9, 1997, K971358.
510k, Surgicraft Bone Tie, Sep. 25, 1998, K982719.
Karlsson et al, Repair of Bankart lesions with a suture anchor in recurrent dislocation of the shoulder, Scand. j. of Med & Science in Sports, 1995, 5:170-174.
Madjar et al, Minimally Invasive Pervaginam Procedures, for the Treatment of Female Stress Incontinence . . . , Artificial Organs, 22 (10) 879-885, 1998.
Nowak et al, Comparative Study of Fixation Techniques in the Open Bankart Operation Using Either a Cannulated Screw or Suture-Anchors, Acta Orthopcedica Belgica, vol. 64—Feb. 1998.
Packer et al, Repair of Acute Scapho-Lunate Dissociation Facilitated by the “Tag.” Suture Anchor, Journal of Hand Surgery (British and European vol. 1994) 19B: 5: 563-564.
Richmond, Modificatio of the Bankart reconstruction with a suture anchor, Am J Sports Med, vol. 19, No. 4, p. 343-346, 1991.
Shea et al, Technical Note: Arthroscopic Rotator Cuff Repair Using a Transhumeral Approach to Fixation, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 14, No. 1 Jan.-Feb. 1998: pp. 118-122.
Tfix, Acufex just tied the knot . . . , Am. J. Sports Med., vol. 22, No. 3, May-Jun. 1994.
Wong et al, Case Report: Proper Insertion Angle Is Essential to Prevent Intra-Articular Protrusion of a Knotless Suture Anchor in Shoulder Rotator Cuff Repair, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 26, No. 2 Feb. 2010: pp. 286-290.
Cobb et al, Late Correction of Malunited Intercondylar Humeral Fractures Intra-Articular Osteotomy and Tricortical Bone Grafting, J BoneJointSurg [Br] 1994; 76-B:622-6.
Fellinger, et al, Radial avulsion of the triangular fibrocartilage complex in acute wrist trauma: a new technique for arthroscopic repair, Jun. 1997, Arthroscopy vol. 13 No. 3 p. 370-4.
Hecker et al , Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs, Nov.-Dec. 1993 , The American Journal of Sports Medicine, vol. 21 No. 6 p. 874-9.
Hernigou et al , Proximal Tibial Osteotomy for Osteoarthritis with Varus Deformity a Ten to Thirteen-Year Follow-Up Study, J Bone Joint Surg, vol. 69-A, No. 3. Mar. 1987, p. 332-354.
Ibarra et al, Glenoid Replacement in Total Shoulder Arthroplasty, The Orthopedic Clinics of Northamerica: Total Shoulder Arthroplasty, vol. 29 No. 3, Jul. 1998 p. 403-413.
Mosca et al, Calcaneal Lengthening for Valgus Deformity of the Hindfoot: Results in Children Who Had Severe, Symptomatic fLATFOOT and Skewfoot, J Bone Joint Surg,, 1195—p. 499-512.
Murphycet al , Radial Opening Wedge Osteotomy in Madelung's Deformity, J. Hand Surg, vol. 21 A No. 6 Nov. 1996, p. 1035-44.
Biomet, Stanmore Modular Hip, J. Bone Joint Surg., vol. 76-B : No. Two, Mar. 1994.
Intl Prelim Rep on Patentability and Written Opinion for PCT/US10/25263 dated Aug. 30, 2011.
IPR—International Publication WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948.
ISR—International Search Report WO/2008/116203, published Dec. 24, 2008 for PCT/US08/57948.
IPER—Internation Preliminary Report on Patentability, WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948.
Written Opinion WO/2008/116203 dated Oct. 23, 2008 for PCT/US08/57948.
IPR—International Publication WO2009/029908, published May 3, 2009 for PCT/US08/74941.
ISR—International Search Report, WO2009/029908, published May 3, 2009 for PCT/US08/74941.
IPER—Internation Preliminary Report on Patentability, WO2009/029908, published Mar. 2, 2010 for PCT/US08/74941.
Written Opinion WO2009/029908 dated Feb. 28, 2010 for PCT/US08/74941.
International Search Report PCT/US2010/025263 completed Apr. 13, 2010.
Written Opinion for PCT/US2010/025263 completed Apr. 13, 2010.
The Search for the Holy Grail: A Centrury of Anterior Cruciate Ligament Reconstruction, R. John Naranja, American Journal of Orthopedics, Nov. 1997.
Femoral Bone Plug Recession in Endoscope Anterior Cruciate Ligament Reconstruction, David E. Taylor, Arthroscopy: The Journal of Arthroscopic and Related Surgery, Aug. 1996.
Meniscus Replacement with Bone Anchors: A Surgical Technique, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 1994.
Problem Solving Report Question No. 1014984.066, Ultrasonic Welding, (c) 1999.
Guide to Ultrasound Plastic Assembly, Ultrasonic Division Publication, (c) 1995.
Branson, Polymers: Characteristics and Compatibility for Ultrasonic Assembly, Applied Technologies Group, Publication unknown.
Enabling Local Drug Delivery-Implant Device Combination Therapies, Surmodics, Inc., (c) 2003.
Stent Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Takeshi Suzuki, American Heart Association, Inc. (c) 2001.
Why Tie a Knot When You Can Use Y-Knot?, Innovasive Devices Inc., (c) 1998.
Ask Oxford, compact Oxford English dictionary: projection, Mar. 30, 2009.
Ask Oxford, compact Oxford English dictionary: slit, Mar. 30, 2009.
Textured Surface Technology, Branson Technolog, Branson Ultrasonics Copr., (c) 1992.
IPR—International Publication WO/2007/092869, publishedAug. 16, 2007 for PCT/US2007/061730.
ISR—International Search Report WO/2007/092869, published Dec. 13, 2007 for PCT/US2007/061730.
Intl Prelim Report on Patentability, WO/2007/092869, published Aug. 12, 2008 for PCT/US2007/061730.
Written Opinion WO/2007/092869 dated Aug. 7, 2008 for PCT/US2007/061730.
Petition for Inter Partes Review of U.S. Pat. No. 5,980,559, IPR 2013-00603, Filing Date Sep. 24, 2013.
Declaration of David Kaplan, Ph.D. Regarding U.S. Pat. No. 5,980,559, IPR 2013-00603, Sep. 24, 2013.
Petition for Inter Partes Review of U.S. Pat. No. 7,087,073, IPR 2013-00604, Filing Date Sep. 24, 2013
Declaration of Wayne J. Sebastianelli, MD Regarding U.S. Pat. No. 7,087,073, Sep. 24, 2013, IPR 2013-00604.
Petition for Inter Partes Review of U.S. Pat. No. 6,500,195, IPR 2013-00624, Filing Date Oct. 2, 2013.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Pat. No. 6,500,195, IPR 2013-00624, Sep. 25, 2013.
Petition for Inter Partes Review of U.S. Pat. No. 5,527,343, IPR 2013-00628, Filing Date Sep. 26, 2013, Sep. 25, 2013.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Pat. No. 5,527,343, IPR 2013-00628, Sep. 25, 2013.
Corrected Petition for Inter Partes Review of U.S. Pat. No. 5,921,986, IPR 2013-00631, Filing Date Sep. 27, 2013.
Expert Declaration of Steve E. Jordan, MD, for Inter Partes Review of U.S. Pat. No. 5,921,986, IPR 2013-00631, Sep. 24, 2013.
Corrected Petition for Inter Partes Review of U.S. Pat. No. 8,147,514, IPR 2013-00632, Filing Date Sep. 27, 2013.
Declaration of Steve Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00632, dated Sep. 23, 2013 (exhibit 1009).
Corrected Petition for Inter Partes Review of U.S. Pat. No. 8,147,514, IPR 2013-00633, Filing Date Sep. 27, 2013.
Declaration of Steve Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00633, dated Sep. 23, 2013 (exhibit 1006).
Flory, Principles of Polymer Chemistry, 1953, selected pages (cited in IPR 2013-00603, exhibit 1012).
Grizzi, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 1995, vol. 16, No. 4, p. 305-11 (cited in IPR 2013-00603, exhibit 1006).
Gopferich, Mechanisms of polymer degradation and erosion, Biomaterials, 1996, vol. 17, No. 2, p. 103-114 (cited in IPR 2013-00603, exhibit 1013).
Gao et el, Swelling of Hydroxypropyl Methylcellulose Matrix Tablets . . . , J. of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, p. 732-740 (cited in IPR 2013-00603, exhibit 1014).
Linvatec, Impact Suture Anchor brochure, 2004 (cited in IPR 2013-00628, exhibit 1010).
Seitz et al, Repair of the Tibiofibular Syndesmosis with a Flexible Implant, J. of Orthopaedic Trauma, vol. 5, No. 1, p. 78-82, 1991 (cited in IPR 2013-00631, exhibit 1007) (cited in 2013-00632).
Translation of FR2696338 with translators certificate dated Sep. 17, 2013 (cited in IPR 2013-00631, 2013-00632).
Translation of DE9002844.9 with translator's certificate dated Sep. 26, 2013 (cited in IPR 2013-00631, 2013-00632).
Declaration of Steve Jordan for U.S. Pat. No. 5,921,986, from IPR 2013-00632, dated Sep. 24, 2013 (exhibit 1010).
Declaration of Steve Jordan for U.S. Pat. No. 5,921,986, from IPR 2013-00633, dated Sep. 24, 2013 (exhibit 1007).
Declaration of Dr. Steve E. Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00631, dated Sep. 23, 2013.
Related Publications (1)
Number Date Country
20140194907 A1 Jul 2014 US
Provisional Applications (1)
Number Date Country
61749261 Jan 2013 US